	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S20-PMC2290997	PMC2290997	4/2008	S20-PMC2290997	['the initial Photosynthesis produces Vitamin D3, most of which undergoes additional transformations, starting with the production of 25-Hydroxyvitamin D (25[Oh]D), the major form of Vitamin D circulating in the Bloodstream and the form that is routinely measured to determine a Person’s Vitamin D status.']	N/A	N/A	[('GO_0006654', 'phosphatidic acid biosynthetic process', 12, 'photosynthesis'), ('CHEBI_33279', 'vitamin D5', 36, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 36, 'vitamin D3'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 132, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 153, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 210, 'bloodstream'), ('NCBITaxon_10088', 'Mus <genus>', 277, 'person'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D')]
S184-PMC2290997	PMC2290997	4/2008	S184-PMC2290997	['in sunlight-related research, there are two main exposures of interest: Vitamin D status, which is measured by the Serum 25(Oh)D level; and personal uvr dose, which involves three fundamental factors: ambient uvr (a function of latitude, altitude, atmospheric Ozone levels, pollution, and time of year), amount of skin exposed (a function of behavioral, cultural, and clothing practices), and skin pigmentation (with dark skin receiving a smaller effective dose to underlying structures than light skin).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 121, '25(OH ... D'), ('CHEBI_25812', 'ozone', 260, 'ozone')]
S40-PMC2798111	PMC2798111	12/2010	S40-PMC2798111	['the Vitamin D status of those infants in the control group who received 400\u2009iu/day Vitamin D3Was measured by circulating 25(Oh)D at 1, 4, and 7 months of age.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_73754', 'thiosugar', 83, 'vitamin D3was'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 83, 'vitamin D3was'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 121, '25(OH ... D')]
S46-PMC2963768	PMC2963768	10/2010	S46-PMC2963768	['comparisons were made between groups of participants categorized by Vitamin D status using a 25-nmol/l cut-off.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
S50-PMC2963768	PMC2963768	10/2010	S50-PMC2963768	"[""other than age and 25(Oh)D, which were compared across groups by one-way analysis of variance, the statistical significance of bivariate associations between the Vitamin D status and the maternal, infant or household characteristics in the entire sample (n=74) was assessed by non-parametric tests, including chi-square tests, mann-u whitney tests, and spearman's rank correlation coefficient.""]"	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 19, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
S82-PMC2963768	PMC2963768	10/2010	S82-PMC2963768	['comparison of selected characteristics of infants and toddlers categorized by Vitamin D status in sylhet, bangladeshcharacteristics25(Oh)D <25 nmol/l25(Oh)d ≥25 nmol/lp valueno.2450mean 25(Oh)D±sd16.3±5.840.5±11.8<0.001age (mean days±sd)71.3±43.4136.6±126.7<0.001<6 months23 (96)39 (78)0.051boys21 (88)40 (80)0.427birth-order (median±iqr)2±4.52±50.455anthropometric indicators\xa0\xa0underweight11 (46)25 (48)0.861\xa0\xa0stunted10 (42)16 (32)0.415\xa0\xa0low body mass index14 (58)20 (40)0.138age of mothers (mean years±sd)23.7±5.624.8±5.30.410years of schooling of mother (median±iqr)1.5±6.55±60.613years of schooling of father (median±iqr)0±54±50.177family owns their own homestead14 (58)32 (64)0.638manufactured housing materials (i.e.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 133, '(OH)D'), ('CHEBI_33310', 'neon atom', 151, '(OH)'), ('CHEBI_71657', 'versiconol acetate', 186, '25(OH)D')]
S3-PMC3004407	PMC3004407	12/2010	S3-PMC3004407	['a single Blood sample was taken to measure circulating 25(Oh)D as indicator of Vitamin D status [25(Oh)D < 20\u2009ng/ml (50\u2009nmol/l deficiency; <32\u2009ng/ml (80\u2009nmol/l) insufficiency].']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 99, '(OH ... D')]
S92-PMC3004407	PMC3004407	12/2010	S92-PMC3004407	['Vitamin D status as measured by 25(Oh)D was also analyzed by season: after controlling for race, there was no significant evidence of seasonal variation in the prevalence of Vitamin D insufficiency and/or deficiency in this population.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
S9-PMC3034879	PMC3034879	12/2010	S9-PMC3034879	['results\nthe children were divided into two groups based on Vitamin D status during Pregnancy.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
S37-PMC3034879	PMC3034879	12/2010	S37-PMC3034879	['maternal Vitamin D status was assessed in communal Prenatal clinics during the first trimesters as part of normal follow-up.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'prenatal')]
S91-PMC3034879	PMC3034879	12/2010	S91-PMC3034879	['for data analysis, the participants were divided into two groups based on maternal Vitamin D status during Pregnancy.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy')]
S107-PMC3034879	PMC3034879	12/2010	S107-PMC3034879	['squares indicate high d and circles indicate low d\n\ncaption (table-wrap): table\xa03\n\ndistribution of Vitamin D status in 1-year-old children and mean intake in each categorys-25-Ohd (nmol/l) n (%)total intake of Vitamin D (μg/day)auser of d2(%)b<37.52 (2.3)12.2 (4.0)10037.6–5016 (18.6)10.6 (3.1)10050.1–79.953 (61.6)12.4 (2.8)88.5≥8015 (17.4)13.1 (2.5)50total (n)868484\natotal Intake differed between categories of 25-Ohd (anova; p \u2009=\u20090.03)\nbdistribution of d2users differed between categories (chi square; p \u2009=\u20090.001)\n\nTibia bmc, csa and bmd\nbone measurements were successful in 68 of subjects (78%) at the 14-month visit.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 173, '25-OHD'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007631', 'feeding behavior', 376, 'intake'), ('CHEBI_72765', 'verruculogen', 414, '25-OHD'), ('UBERON_0000979', 'tibia', 519, 'Tibia')]
S139-PMC3034879	PMC3034879	12/2010	S139-PMC3034879	['firstly, distal Tibia csa remained larger at 14\xa0months in infants with higher maternal Vitamin D status during Pregnancy than in infants with lower maternal Vitamin D status.']	N/A	N/A	[('UBERON_0000979', 'tibia', 16, 'tibia'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S140-PMC3034879	PMC3034879	12/2010	S140-PMC3034879	['secondly, the increment in Tibial bmc from Birth to 14\xa0months was higher in those with inferior maternal Vitamin D status during Pregnancy.']	N/A	N/A	[('UBERON_0002101', 'limb', 27, 'tibial'), ('GO_0007567', 'parturition', 43, 'birth'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
S151-PMC3034879	PMC3034879	12/2010	S151-PMC3034879	['maternal Vitamin D status Regulates Skeletal growth and Development during fetal Life [9,10,28].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 26, 'regulates'), ('GO_0001501', 'skeletal system development', 36, 'skeletal ... development'), ('UBERON_0004288', 'skeleton', 36, 'skeletal'), ('UBERON_0000104', 'life cycle', 81, 'life')]
S32-PMC3103150	PMC3103150	3/2011	S32-PMC3103150	['clinical and anthropometric data:\ndetails regarding mode of Feeding of infant, supplementation of any Vitamin or Calcium to infant, mothers’ diet, Intake of Calcium and Vitamin D supplements during Pregnancy and after Delivery, education and profession, financial status of the family and usual duration and type of clothing worn during sunlight exposure for both infant and mother were recorded in a case record form.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 60, 'feeding'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('CHEBI_22313', 'alkaline earth metal atom', 113, 'calcium'), ('GO_0007631', 'feeding behavior', 147, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 157, 'calcium'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('GO_0007567', 'parturition', 218, 'delivery')]
S45-PMC3103150	PMC3103150	3/2011	S45-PMC3103150	['the radiographs were interpreted by a single radiologist, experienced in reporting of paediatric radiographs, who was blinded to the biochemical Vitamin D status of the infants.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
S14-PMC3257641	PMC3257641	3/2010	S14-PMC3257641	['both sunlight-derived (Vitamin D3) or Ingested (Vitamin D2Or Vitamin D3) Vitamin D are transported to the Liver where 25-hydroxylase enzymes catalyze conversion to the primary storage form (and the usual Serum measure of Vitamin D status), 25-Hydroxyvitamin D (25(Oh)D) [4].']	N/A	N/A	[('CHEBI_33279', 'vitamin D5', 23, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 23, 'vitamin D3'), ('GO_0007631', 'feeding behavior', 38, 'ingested'), ('CHEBI_27329', 'xanthosine phosphate', 48, 'vitamin D2or'), ('PR_000017209', 'utrophin', 48, 'vitamin D2or'), ('CHEBI_33279', 'vitamin D5', 61, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 61, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0002107', 'liver', 106, 'liver'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 240, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 261, '25(OH)D')]
S50-PMC3296991	PMC3296991	2/2012	S50-PMC3296991	['infants included in this analysis did not differ significantly from those who underwent dxa scans but were not included or who were eligible but did not return for the dxa visit in gender, maternal age, body mass index, l*, parity, or maternal or cord Vitamin D status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
S206-PMC3347028	PMC3347028	3/2012	S206-PMC3347028	['no differences were noted between groups in baseline 25(Oh)D ( p = 0.24), but differences between groups were noted in Vitamin D status within one month of Delivery ( p< 0.0001) and in Cord Blood ( p = 0.0001), with improved status in the 4000-iu group overall.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'delivery'), ('UBERON_0002240', 'spinal cord', 185, 'cord'), ('UBERON_0000178', 'blood', 190, 'blood')]
S37-PMC3395583	PMC3395583	7/2012	S37-PMC3395583	"[""average predicted uvb exposure as well as Vitamin D status during the first, second and third Trimesters of Gestation were calculated for each month of Birth and tested for correlation with risk of id (monthly or) using the spearman's correlation coefficient.""]"	N/A	N/A	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 94, 'trimesters'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('GO_0007567', 'parturition', 152, 'birth')]
S270-PMC3407995	PMC3407995	7/2012	S270-PMC3407995	['a cross-sectional study in iran included 147 Pregnant women whose Serum status of Vitamin D, a, and e were assessed at 5–9 months of Pregnancy.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 45, 'pregnant'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy')]
S279-PMC3407995	PMC3407995	7/2012	S279-PMC3407995	['a cross-sectional study including 50 women in labour with a singleton term Pregnancy in pakistan measured Vitamin D status in maternal Blood before Delivery and Cord Blood at Delivery.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0000178', 'blood', 135, 'blood'), ('GO_0007567', 'parturition', 148, 'delivery'), ('UBERON_0002240', 'spinal cord', 161, 'cord'), ('UBERON_0000178', 'blood', 166, 'blood'), ('GO_0007567', 'parturition', 175, 'delivery')]
S20-PMC3427250	PMC3427250	8/2012	S20-PMC3427250	['as few Food items contain or are fortified with Vitamin D (such as Liver, fatty fish, eggs, milk and dairy products, soy milk, butter, margarines), the skin Synthesis Of Vitamin D induced by ultraviolet b radiation (uvb) is the main determinant of Vitamin D status in the population[23].']	N/A	N/A	[('CHEBI_33290', 'food', 7, 'food'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0002107', 'liver', 67, 'liver'), ('GO_0030474', 'spindle pole body duplication', 157, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
S55-PMC3427250	PMC3427250	8/2012	S55-PMC3427250	['the odds of having a Serum 25-(Oh)D concentration lower than 20 ng/ml (Vitamin D deficiency) versus a non deficient Vitamin D status were estimated through multiple logistic regressions while entering the following variables as predictors in the model: season, age, Trimester Of Pregnancy, region, bmi, smoking behaviour, alcohol Consumption, use of Vitamin D-containing Food supplements, fish Consumption, milk and dairy product Consumption, education level, ethnicity, parity, exposure to sunlight during weekdays, exposure to sunlight during weekend days, use of sunscreen Lotion, use of solarium, shadow or sun preference and sometimes going on holidays to sunny climates (yes/no question).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 21, 'serum'), ('CHEBI_72657', '19,20-DiHDPA', 27, '25-(OH)D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 266, 'trimester of pregnancy'), ('GO_0007631', 'feeding behavior', 330, 'consumption'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('CHEBI_33290', 'food', 371, 'food'), ('GO_0007631', 'feeding behavior', 394, 'consumption'), ('GO_0007631', 'feeding behavior', 430, 'consumption'), ('CHEBI_75903', 'arsenic(1-) sulfides', 576, 'lotion')]
S56-PMC3427250	PMC3427250	8/2012	S56-PMC3427250	['in addition the odds of having a Serum 25-(Oh)D concentration lower than 10 ng/ml (severe Vitamin D deficiency) versus a non severe deficient Vitamin D status were estimated through multiple logistic regressions while entering the same predictors in the model.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('CHEBI_72657', '19,20-DiHDPA', 39, '25-(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
S61-PMC3427250	PMC3427250	8/2012	S61-PMC3427250	['for 1 hospital (n\u200a=\u200a23 women) certain questions (mainly nationality, ethnicity, education level) needed to be omitted from the questionnaire upon decision of the ethical committee of this particular hospital.10.1371/journal.pone.0043868.g001\n\ncaption (fig): figure 1\ngeographical distribution of the 55 hospitals visited in belgium and the number of Pregnant women (n\u200a=\u200a1311) investigated by site (national survey on Vitamin D status of Pregnant women belgium 2010–2011).10.1371/journal.pone.0043868.t001\n\ncaption (table-wrap): table 1\nnumber of Pregnant women by region, trimester and age (national survey on Vitamin D status among Pregnant women belgium, 2010–2011).regionsbrussels**flanders**walloniaage(years )1sttrimester3rdtrimester1sttrimester3rdtrimester1sttrimester3rdtrimester15–20721110211721–2534277751567326–304139108149765831–3534536975494536–4014142319132441–45231332total132138289307218219\n6 missing data for age.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 350, 'pregnant'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('GO_0007565', 'female pregnancy', 437, 'pregnant'), ('GO_0007565', 'female pregnancy', 546, 'pregnant'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('GO_0007565', 'female pregnancy', 633, 'pregnant')]
S76-PMC3427250	PMC3427250	8/2012	S76-PMC3427250	['the percentage of women with Vitamin D insufficiency and deficiency was higher in the first than in the third Trimester of Pregnancy but the prevalence of severe Vitamin D deficiency was higher in the third trimester (table 3).10.1371/journal.pone.0043868.t003\n\ncaption (table-wrap): table 3\nSerum 25-(Oh)D concentration in Pregnant women (n\u200a=\u200a1311) (belgian national survey on Vitamin D status in Pregnant women, 2010–2011).all womenwalloniaflanders1sttrimester3rdtrimestern1300453633633665age28.5±5.127.9±5.528.8±4.728.3±5.128.8±5.1gestational weeks22.2±12.522.1±12.822.4±12.39.9±2.834.1±3.625-(oh)d(ng/ml)median21.220.922.320.422.7*iqr13.8–30.013.5–29.114.6–30.613.6–26.714.3–34.195% ci20.5–22.219.8–22.321.2–23.219.3–21.121.6–24.4% <10 ng/ml12.112.310.911.612.6% <20 ng/ml44.645.742.347.042.3% <30 ng/ml74.176.372.582.266.7\ndifferent from first Trimester Pregnant women, p<0.001.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 110, 'trimester'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 292, 'Serum'), ('CHEBI_72657', '19,20-DiHDPA', 298, '25-(OH)D'), ('GO_0007565', 'female pregnancy', 324, 'pregnant'), ('CHEBI_27300', 'vitamin D', 378, 'vitamin D'), ('GO_0007565', 'female pregnancy', 398, 'pregnant'), ('GO_0009294', 'DNA mediated transformation', 849, 'trimester'), ('GO_0007565', 'female pregnancy', 859, 'pregnant')]
S78-PMC3427250	PMC3427250	8/2012	S78-PMC3427250	['women of other ethnic origins were Vitamin D deficient (25-(Oh)D concentration <20 ng/ml) all year round, except during summer for third trimester women (figure 2).10.1371/journal.pone.0043868.g002\n\ncaption (fig): figure 2\nSerum 25-(Oh)d concentrations over the different seasons, by Trimester of Pregnancy and ethnicity (national survey on Vitamin D status among Pregnant women in belgium, 2010–2011).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_72657', '19,20-DiHDPA', 56, '25-(OH)D'), ('UBERON_0001977', 'blood serum', 223, 'Serum'), ('CHEBI_30254', 'sulfidocarbon(.1+)', 229, '25-(OH)'), ('GO_0009294', 'DNA mediated transformation', 284, 'trimester'), ('GO_0007565', 'female pregnancy', 297, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D'), ('GO_0007565', 'female pregnancy', 364, 'pregnant')]
S45-PMC3470091	PMC3470091	9/2012	S45-PMC3470091	['patients’ Vitamin D status was determined by measuring Serum 25(Oh) Vitamin D3 concentration.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_30778', 'gallic acid', 61, '25(OH)'), ('CHEBI_33279', 'vitamin D5', 68, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 68, 'vitamin D3')]
S14-PMC3476426	PMC3476426	8/2012	S14-PMC3476426	['Vitamin D3 undergoes a 25-hydroxylation in the Liver, with the resulting product, 25-Hydroxy Vitamin D or Calcidiol, being the main circulating form of Vitamin D. therefor, 25-Hydroxy Vitamin D levels are used to determine the Vitamin D status of a given Individual [1,2].']	N/A	N/A	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('UBERON_0002107', 'liver', 47, 'liver'), ('CHEBI_43141', '3-hydroxypropoxy group', 82, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 101, 'D'), ('CHEBI_17933', 'calcidiol', 106, 'calcidiol'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 173, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('NCBITaxon_1', 'root', 255, 'individual')]
S38-PMC3521768	PMC3521768	12/2012	S38-PMC3521768	['Pregnant women were classified based on their Prenatal Serum zinc and Vitamin A statuses and followed until Birth.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007565', 'female pregnancy', 46, 'prenatal'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('GO_0007567', 'parturition', 108, 'birth')]
S47-PMC3521768	PMC3521768	12/2012	S47-PMC3521768	['study subjects\nPregnant women whose zinc and Vitamin A statuses were determined at their second or third Trimester and who later gave singleton live-Births were eligible for the study.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 15, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin A'), ('GO_0009294', 'DNA mediated transformation', 105, 'trimester'), ('GO_0007567', 'parturition', 149, 'births')]
S136-PMC3521768	PMC3521768	12/2012	S136-PMC3521768	['maternal zinc and Vitamin A statuses and lbw\nstandard cutoff points were applied to define Prenatal zd (Serum zinc <7.6 µmol/l[29]) and vad (Serum Retinol <0.7 µmol/l[30]).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('CHEBI_26536', 'retinoic acid', 147, 'retinol')]
S213-PMC3641012	PMC3641012	4/2013	S213-PMC3641012	['discussion\namong Pregnant women with relatively low average baseline Vitamin D status in dhaka, 3rd-Trimester Vitamin D3 supplementation (35,000\xa0iu/week) significantly raised maternal and neonatal (Cord Blood) Serum 25(Oh)D concentrations above the iom cut-off for sufficiency (50\xa0nmol/l) in virtually all participants without inducing hypercalcemia or other apparent short-term clinical adverse effects.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 100, 'trimester'), ('CHEBI_33279', 'vitamin D5', 110, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 110, 'vitamin D3'), ('UBERON_0002240', 'spinal cord', 198, 'cord'), ('UBERON_0000178', 'blood', 203, 'blood'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 216, '25(OH ... D')]
S28-PMC3659910	PMC3659910	1/2013	S28-PMC3659910	['however, these children represent a small proportion of the Individuals with a suboptimal Vitamin D status in the population.']	N/A	N/A	[('NCBITaxon_1', 'root', 60, 'individuals'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
S151-PMC3659910	PMC3659910	1/2013	S151-PMC3659910	['a study in Pregnant women in south india assessed maternal Vitamin D status by measuring Serum 25-Hydroxyvitamin D in stored Serum samples.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 11, 'pregnant'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 95, '25-hydroxyvitamin D'), ('UBERON_0001977', 'blood serum', 125, 'serum')]
S6-PMC3672018	PMC3672018	5/2013	S6-PMC3672018	['additionally, a validated method will be used to determine neonatal Vitamin D status using stored dried Blood spots (dbs) from Individuals who developed the aforementioned disease entities as Adults and their time and gender-matched controls.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000178', 'blood', 104, 'blood'), ('NCBITaxon_1', 'root', 127, 'individuals'), ('UBERON_0007023', 'adult organism', 192, 'adults')]
S53-PMC3672018	PMC3672018	5/2013	S53-PMC3672018	['additionally, a validated method will be used to determine neonatal Vitamin D status using stored dried Blood spots (dbs) from Individuals who develop the aforementioned disease entities as Adults and their time and gender-matched controls.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000178', 'blood', 104, 'blood'), ('NCBITaxon_1', 'root', 127, 'individuals'), ('UBERON_0007023', 'adult organism', 190, 'adults')]
S3-PMC3691177	PMC3691177	6/2013	S3-PMC3691177	['supplementation improved but did not optimise Vitamin D status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S135-PMC3691177	PMC3691177	6/2013	S135-PMC3691177	['the doses of supplementation were chosen pragmatically, were not stratified based on individual Vitamin D status or genotype, and response to treatment was not monitored before Delivery.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 177, 'delivery')]
S8-PMC3702245	PMC3702245	6/2013	S8-PMC3702245	['very few Food items, including fatty fish, fortified dairy products, and Egg Yolk, contain Vitamin D.9,10when exposure to sunlight is limited, Individuals depend on dietary sources or Vitamin D supplements to maintain adequate Vitamin D status.']	N/A	N/A	[('CHEBI_33290', 'food', 9, 'food'), ('UBERON_0007378', 'egg yolk', 73, 'egg yolk'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('NCBITaxon_1', 'root', 143, 'individuals'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
S12-PMC3702245	PMC3702245	6/2013	S12-PMC3702245	['restoration of Vitamin D status and calcium balance allows calcium accretion in the Bones.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001474', 'bone element', 84, 'bones')]
S66-PMC3702245	PMC3702245	6/2013	S66-PMC3702245	['these subjects with very low Vitamin D status were started on 800 iu/day of Vitamin D, increased to 1600 iu/day at 36 weeks’ Gestation if Serum 25(Oh)D was still low.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'gestation'), ('UBERON_0001977', 'blood serum', 138, 'serum'), ('CHEBI_71657', 'versiconol acetate', 144, '25(OH)D')]
S200-PMC3702339	PMC3702339	6/2013	S200-PMC3702339	['distance from the nearby health facility, Prenatal nutrition education/counselling, and frequency of anc were not associated with Vitamin A status.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin A')]
S117-PMC3705320	PMC3705320	3/2013	S117-PMC3705320	['there was no significant association between baseline Vitamin D status and ∆[25(Oh)D] (data not shown).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D')]
S23-PMC3760821	PMC3760821	9/2013	S23-PMC3760821	['during Pregnancy, 25Ohd diffuses across the Placental barrier, meaning the Foetus relies entirely on the Vitamin D status of the mother[9].']	N/A	N/A	"[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 18, '25OHD'), ('UBERON_0001987', 'placenta', 44, 'placental'), ('UBERON_0000376', 'hindlimb stylopod', 75, 'foetus'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]"
S3-PMC3773018	PMC3773018	4/2013	S3-PMC3773018	['we defined fs as specific Ige ≥0.35kua/l to any of eight common Food Allergens; and persistently low Vitamin D status as Cord Blood 25(Oh)D <11ng/ml and Postnatal 25(Oh)D <30ng/ml.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 26, 'IgE'), ('CHEBI_33290', 'food', 64, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 69, 'allergens'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 121, 'cord'), ('UBERON_0000178', 'blood', 126, 'blood'), ('CHEBI_33010', 'chromide(1-)', 134, '(OH)D'), ('GO_0007567', 'parturition', 153, 'postnatal'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 169, 'D')]
S5-PMC3773018	PMC3773018	4/2013	S5-PMC3773018	['there was no association between low Vitamin D status and fs at any single time point alone.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
S36-PMC3773018	PMC3773018	4/2013	S36-PMC3773018	['persistently low Vitamin D status was defined as having low levels at both time points.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
S45-PMC3773018	PMC3773018	4/2013	S45-PMC3773018	['similarly, the proportions of children with low Vitamin D status at Birth (i.e., <11ng/ml), <1year, 1–2 years, and 2–3 years (i.e., <30ng/ml) were 38%, 29%, 36%, and 40%, respectively; and the correlation coefficients between Cord Blood 25(Oh)D concentrations and 25(Oh)D measures up to age 1 year, 1–2 years, and 2–3 years were 0.28, 0.39, and 0.63, respectively.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'birth'), ('UBERON_0009472', 'axilla', 226, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 237, '25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 264, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 264, '25(OH ... D')]
S52-PMC3773018	PMC3773018	4/2013	S52-PMC3773018	['individually, neither Cord Blood nor Postnatal low Vitamin D status was significantly associated with any fs (table 3).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('GO_0007567', 'parturition', 37, 'postnatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
S26-PMC3827489	PMC3827489	10/2013	S26-PMC3827489	['epidemiology of Vitamin D status\n\n1.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
S38-PMC3827489	PMC3827489	10/2013	S38-PMC3827489	['predictors of Vitamin D insufficiency or deficiency\nthe main risk factors for Vitamin D insufficiency or deficiency in the pediatric population are season (winter), insufficient time spent outdoors, non-white ethnicity, older age, more advanced stage of puberty, obesity, low milk consumption, low socioeconomic status, and female gender19).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S96-PMC3901983	PMC3901983	1/2013	S96-PMC3901983	['furthermore, Vitamin A deficiency also impairs iron status, increases susceptibility to Respiratory infections and diarrhea, and increases morbidity and mortality.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 88, 'respiratory')]
S242-PMC4045304	PMC4045304	2/2014	S242-PMC4045304	['in a study of nonautistic children with 25-Hydroxy D levels below 10\u2009ng/ml (poor Vitamin D status), Insulin resistance was 7 times higher than that in children with Vitamin D levels above 30\u2009ng/ml [103].']	N/A	N/A	"[('CHEBI_52306', ""2',7'-difluorofluorescein"", 40, '25-hydroxy D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('PR_000045358', 'insulin family protein', 100, 'insulin'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]"
S22-PMC4113768	PMC4113768	7/2014	S22-PMC4113768	['results: median (25th–75th percentiles) Vitamin D status was 64(52–72) nmol/l.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S130-PMC4113768	PMC4113768	7/2014	S130-PMC4113768	['in asians there was no significant correlation between Vitamin D status and any Tibial bone parameter ( p> 0.05).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0002101', 'limb', 80, 'tibial')]
S523-PMC4113768	PMC4113768	7/2014	S523-PMC4113768	['the effect of the intervention on co-primary outcomes did not differ according to baseline Vitamin D status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
S524-PMC4113768	PMC4113768	7/2014	S524-PMC4113768	['conclusions: intermittent bolus-dose Vitamin D supplementation significantly improved Vitamin D status but did not influence time to exacerbation or time to uri in a population of adults with ics-treated asthma and a high prevalence of Vitamin D deficiency at baseline.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
S744-PMC4113768	PMC4113768	7/2014	S744-PMC4113768	['background: laboratory measurement of Serum 25-Hydroxy Vitamin D [25(Oh)D] concentration is used to assess an Individual’s Vitamin D status.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 44, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('NCBITaxon_1', 'root', 110, 'individual'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
S754-PMC4113768	PMC4113768	7/2014	S754-PMC4113768	['eight national surveys from australia, canada, germany, ireland, mexico, korea, uk and usa are participating in an effort to characterize Vitamin D status around the world.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
S1157-PMC4113768	PMC4113768	7/2014	S1157-PMC4113768	['; de jongh, r.t.; den heijer, m.; visser, m.; merlijn, t.; lips, p.; van schoor, n.m.\nbackground: Vitamin D status is currently diagnosed by measuring Serum 25-Hydroxy Vitamin D (25(Oh)D).']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 98, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 157, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 179, '25(OH)D')]
S1889-PMC4113768	PMC4113768	7/2014	S1889-PMC4113768	['this has spurred discussion on the best way to improve the Vitamin D status of children.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
S2126-PMC4113768	PMC4113768	7/2014	S2126-PMC4113768	['determinants of Vitamin D status were analyzed in gender-specific multiple linear regression models.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
S2975-PMC4113768	PMC4113768	7/2014	S2975-PMC4113768	['at this point the patient’s Vitamin D status was assessed as insufficient and Vitamin D3Supplementation commenced.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_52915', 'phosphatediyl group', 78, 'vitamin D3supplementation')]
S3082-PMC4113768	PMC4113768	7/2014	S3082-PMC4113768	['supplementation improved but did not optimise Vitamin D status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S3187-PMC4113768	PMC4113768	7/2014	S3187-PMC4113768	['the significant predictors of lower Vitamin D status identified using multivariable logistic regression model were: urban setting, female sex, high maternal education, greater Triceps skinfold thickness, less sun exposure, less body surface area exposed, having television/computer in the home, and high socioeconomic status [aor(2.74–19.57): 95% ci (1.23, 69.21)].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001509', 'triceps brachii', 176, 'triceps')]
S3197-PMC4113768	PMC4113768	7/2014	S3197-PMC4113768	['season of Blood sampling, health, lifestyle, socio-economic and anthropometric data were collected and included as potential predictors of Vitamin D status in regression models.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
S111-PMC4169453	PMC4169453	9/2014	S111-PMC4169453	['the groups were similar in all baseline characteristics, including Vitamin D status (fig.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
S242-PMC4169453	PMC4169453	9/2014	S242-PMC4169453	['furthermore, maternal Vitamin D3 supplementation during Lactation at a dose up to 1200 iu/d had no influence on maternal and infant body composition or infant Vitamin D status.']	N/A	N/A	[('CHEBI_33279', 'vitamin D5', 22, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 22, 'vitamin D3'), ('GO_0007595', 'lactation', 56, 'lactation'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
S24-PMC4188019	PMC4188019	1/2010	S24-PMC4188019	['results of Vitamin D status in the Pregnant flemish population have never been published before.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnant')]
S57-PMC4231606	PMC4231606	10/2013	S57-PMC4231606	['multiple regression analysis was performed for mean 25(Oh)D including independent variables significantly associated with Vitamin D levels on bivariate analysis or known to influence Vitamin D status.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 58, 'D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
S95-PMC4231606	PMC4231606	10/2013	S95-PMC4231606	['those in the s-ecc group were found to have relatively poor Vitamin D status compared to caries-free children.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S100-PMC4231606	PMC4231606	10/2013	S100-PMC4231606	['there was no association between the education level of the primary caregiver and the child’s Vitamin D status with respect to both the mean levels and the proportion with levels\u2009≥\u200975\xa0nmol/l (p\u2009=\u20090.74 and p\u2009=\u20090.35, respectively).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S19-PMC4251419	PMC4251419	12/2014	S19-PMC4251419	['Serum 25(Oh)D levels are used to determine Vitamin D status.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
S57-PMC4256222	PMC4256222	12/2014	S57-PMC4256222	['statistical methods\ncox proportional hazard model was used to investigate the association between total Vitamin D status in Pregnancy and first time bone fracture risk.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
S69-PMC4256222	PMC4256222	12/2014	S69-PMC4256222	['results\nSerum samples were available from 88% of the women in the cohort, which in total provided 850 mother and child pairs with a maternal Vitamin D status from Gestation week 30.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 8, 'Serum'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'gestation')]
S71-PMC4256222	PMC4256222	12/2014	S71-PMC4256222	['the median (5–95 percentile) total Vitamin D status among the 850 Pregnant women was 76.2 (23.0–152.1) nmol/l.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant')]
S72-PMC4256222	PMC4256222	12/2014	S72-PMC4256222	['in our study population, 6.3% had Vitamin D deficiency (<25 nmol/l), 74.5% reached sufficient status (≥50 nmol/l), 37.8% were at the optimal level (75–125 nmol/l) and 13.4% had high status of Vitamin D (>125 nmol/l).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
S75-PMC4256222	PMC4256222	12/2014	S75-PMC4256222	['background characteristics of the mothers according to Vitamin D status are shown intable 1.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
S83-PMC4256222	PMC4256222	12/2014	S83-PMC4256222	['in our data there was no overall association between total Vitamin D status and first time bone fracture (table 2).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
S88-PMC4256222	PMC4256222	12/2014	S88-PMC4256222	['adjustment for status of Vitamin D did not attenuate the association (hr\u200a=\u200a1.82, 95%ci: 1.12–2.97).10.1371/journal.pone.0114334.t002\n\ncaption (table-wrap): table 2\nthe association (hazard ratios and 95% confidence interval) between maternal Vitamin D status in Gestation week 30 and offspring bone fractures in childhood and adolescence among 850 mother and child pairs from the dafo88 cohort in aarhus city, denmark.crudeadjusted*ncaseshr (95% ci)hr (95% ci)all ages, 0–18 y<50 nmol/l)217781.13 (0.84–1.51)1.17 (0.87–1.57)50–75 nmol/l)199741.20 (0.89–1.62)1.19 (0.88–1.61)≥75–125 nmol/l)3211031.001.00>125 nmol/l)113391.09 (0.75–1.58)1.10 (0.76–1.59) p -valuea0.320.27childhood, 0–10 y<50 nmol/l)217391.04 (0.69–1.57)1.07 (0.70–1.62)50–75 nmol/l)199421.25 (0.84–1.87)1.26 (0.84–1.89)≥75–125 nmol/l)321551.001.00>125 nmol/l)113201.06 (0.64–1.78)1.09 (0.65–1.91) p -valuea0.590.53adolescence, 11–18 y<50 nmol/l)178391.23 (0.81–1.88)1.29 (0.84–1.99)50–75 nmol/l)157321.13 (0.72–1.77)1.11 (0.71–1.74)≥75–125 nmol/l)266481.001.00>125 nmol/l)93191.12 (0.66–1.91)1.13 (0.66–1.93) p -valuea0.370.35\n*adjusted for maternal age, pre-Pregnancy bmi, smoking, parity and sex.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'gestation'), ('GO_0007565', 'female pregnancy', 1124, 'pregnancy')]
S89-PMC4256222	PMC4256222	12/2014	S89-PMC4256222	['continuous values of Vitamin D status in the cox regression model.10.1371/journal.pone.0114334.t003\n\ncaption (table-wrap): table 3\nthe association (hazard ratios and 95% confidence interval) between season in Gestation week 30 and offspring bone fractures in childhood and Adolescence among 850 mother and child pairs from the dafo88 cohort in aarhus city, denmark.adjusted*+ vitamin d¤ncaseshr (95% ci)hr (95% ci)all ages, 0–18 ymar/apr/may113351.06 (0.71–1.59)1.05 (0.69–1.59)jun/jul/aug247761.001.00sep/oct/nov3001101.26 (0.94–1.69)1.24 (0.90–1.71)dec/jan/feb190731.39 (1.01–1.92)1.36 (0.96–1.93)childhood, 0–10 ymar/apr/may113211.37 (0.79–2.37)1.42 (0.80–2.50)jun/jul/aug247341.001.00sep/oct/nov300581.45 (0.95–2.22)1.51 (0.95–2.40)dec/jan,/feb190431.75 (1.11–2.74)1.82 (1.12–2.97)adolescence, 11–18 ymar/apr/may92140.82 (0.44–1.50)0.77 (0.41–1.43)jun/jul/aug213421.001.00sep/oct/nov242521.10 (0.73–1.66)1.02 (0.65–1.59)dec/jan,/feb147301.08 (0.67–1.73)0.99 (0.60–1.65)\n*adjusted for maternal age, pre-Pregnancy bmi, smoking, parity and sex.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 209, 'gestation'), ('GO_0048848', 'neurohypophysis morphogenesis', 273, 'adolescence'), ('GO_0007565', 'female pregnancy', 1006, 'pregnancy')]
S90-PMC4256222	PMC4256222	12/2014	S90-PMC4256222	['adjusted for maternal age, pre-Pregnancy bmi, smoking, parity, sex and maternal Vitamin D status in Gestational week 30.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational')]
S95-PMC4256222	PMC4256222	12/2014	S95-PMC4256222	['when we adjusted for maternal status of Vitamin D a significantly higher hr for dec/jan/feb persisted (hr\u200a=\u200a2.17, 95%ci: 1.07–4.39).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S96-PMC4256222	PMC4256222	12/2014	S96-PMC4256222	['discussion\noverall, there was no significant association between maternal Vitamin D status in Gestation week 30 and offspring bone fractures from Birth until 18 years of age in the dafo88 cohort.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'gestation'), ('GO_0007567', 'parturition', 146, 'birth')]
S123-PMC4256222	PMC4256222	12/2014	S123-PMC4256222	['[9]reported 38.7% in their study population to have a Vitamin D status below 50 nmol/l.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
S18-PMC4268639	PMC4268639	11/2014	S18-PMC4268639	['this included assessment of Vitamin D, Carnitine, iron, zinc, and mthfr polymorphism status in the first trimester prior to supplementation.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_17126', 'carnitine', 39, 'carnitine')]
S6-PMC4329404	PMC4329404	10/2014	S6-PMC4329404	['ahr in hdm-exposed Mice was unaffected by Vitamin D status.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 19, 'mice'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S29-PMC4329404	PMC4329404	10/2014	S29-PMC4329404	['as diet is the only source of Vitamin D for rodents (without a contribution from ultraviolet light), we used a Vitamin D-deficient diet to alter vitamin d status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
S73-PMC4329404	PMC4329404	10/2014	S73-PMC4329404	['Lung compliance was also unaffected by Vitamin D status (data not shown).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
S77-PMC4329404	PMC4329404	10/2014	S77-PMC4329404	['Eosinophils in the Bal (fig.2a) and total numbers of Inflammatory Cells in both the Bal and Lung were unaffected by Vitamin D status (fig.2a,b).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophils'), ('UBERON_0006378', 'strand of vibrissa hair', 19, 'BAL'), ('CL_0000902', 'induced T-regulatory cell', 53, 'inflammatory cells'), ('UBERON_0006378', 'strand of vibrissa hair', 84, 'BAL'), ('UBERON_0002048', 'lung', 92, 'lung'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S117-PMC4329404	PMC4329404	10/2014	S117-PMC4329404	['s2) were not influenced by Vitamin D status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
S12-PMC4380518	PMC4380518	9/2014	S12-PMC4380518	['this substudy includes women enrolled from brigham and women’s hospital, a high-risk tertiary Perinatal center in boston, ma who had complete exposure (pnv use) and outcome data (Vitamin D status at two time points during Pregnancy).']	N/A	N/A	[('GO_0036268', 'swimming', 94, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 94, 'perinatal'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy')]
S25-PMC4380518	PMC4380518	9/2014	S25-PMC4380518	['we subsequently stratified by race/ethnicity and obesity status to examine whether pnv was associated with Vitamin D deficiency in high risk groups.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
S41-PMC4396835	PMC4396835	1/2015	S41-PMC4396835	['inclusion criteria for the children with asd were: (1) having been diagnosed with asd without a known cause according to clinical/Neurological assessments, such as rett syndrome, fragile x and tuberous sclerosis during preschool age; (2) having a non-asd sibling aged 4\xa0years or older; and (3) parents giving consent to assessment of Vitamin D status and Cmv-infection status (for a separate study) of the asd and non-asd affected siblings at Birth from dried Blood Spots.']	N/A	N/A	[('UBERON_0001016', 'nervous system', 130, 'neurological'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 355, 'CMV'), ('GO_0007567', 'parturition', 443, 'birth'), ('UBERON_0001969', 'blood plasma', 460, 'blood spots')]
S92-PMC4405493	PMC4405493	4/2015	S92-PMC4405493	['the mean Serum 25-Oh Vitamin D concentration for our study population was 27.6 ng/ml (range 13–71.6 ng/ml).10.1371/journal.pone.0123763.t001\n\ncaption (table-wrap): table 1\nfrequency of clinical outcomes compared to national and global epidemiology.Pregnancy outcome n (% of 235 total)comorbiditiespredicted population us (%)frequencies global (%)madigan 2014 (%) none 176 (75%)-------- Preeclampsia 19 (8%)5 Preterm Deliveries3–10% [22,24–26]2–17% [20,23]3% spontaneous Preterm Delivery 10 (4%)2 iugr, 1 Gdm11.3% [27]9.6% [28]9% iugr 9 (4%)--8.6% [29]3–7% [30]0.6% gdm 5 (2%)--4.6–9.2% [33]4.1–27.5% [36]4% spontaneous Abortion 16 (7%)--8–20% [37,38]6%\niugr, Intrauterine growth restriction; gdm, Gestational diabetes mellitus.10.1371/journal.pone.0123763.t002\n\ncaption (table-wrap): table 2\ndemographics of the study population by Vitamin D classification.totalvitamin D sufficient (>30 ng/ml)Vitamin D insufficient (21–29 ng/ml)Vitamin D deficient (<20 ng/ml)p value**n = 235 (%)n = 70 (30%)n = 141 (60%)n = 24 (10%) age (years) *24.3 ± 4.424.5 ± 4.224.6 ± 4.522.5 ± 3.70.08 Gestational age at analysis (days) *62.2 ± 29.761.8 ± 13.762.2 ± 36.963.0 ± 11.20.99 n (% of 235)n (% of 70)n (% of 141)n (% of 24)p value ** race 0.03 caucasian 183 (77.9)57 (81.4)114 (80.9)12 (50) african american 16 (6.8)3 (4.3)10 (7.1)3 (12.5) asian 6 (2.6)1 (1.4)3 (2.1)2 (8.3) other 30 (12.8)9 (12.9)14 (9.9)7 (29.2) body mass index 0.36 <25 111 (47.2)39 (55.7)62 (44)10 (41.7) 25–30 82 (34.9)21 (30.0)50 (35.5)11 (45.8) >30 42 (17.9)10 (14.3)29 (20.5)3 (12.5) season 0.22 winter 89 (37.9)22 (31.4)61 (43.3)6 (25.0) spring 45 (19.1)16 (22.9)25 (17.7)4 (16.6) summer 53 (22.6)20 (28.6)26 (18.4)7 (29.2) fall 48 (20.4)12 (17.1)29 (20.6)7 (29.2) mode of delivery 0.41 Vaginal 155 (66.0)47 (67.1)95 (67.4)13 (54.2) cesarean section 63 (26.8)18 (25.7)36 (25.5)9 (37.5) iufd or sab 17 (7.2)5 (7.1)10 (7.1)2 (8.3) duty status 0.12 active duty 83 (35.3)22 (31.4)48 (34.0)13 (54.2) dependent 152 (64.6)48 (68.6)93 (66.0)11 (45.8) tobacco use 0.67 yes 15 (6.4)3 (4.3)10 (7.1)2 (8.3) no 220 (93.6)67 (95.7)131 (92.9)22 (91.7)\n*expressed in mean ± standard deviation\n**, p value calculated by analysis of variance for continuous variables and chi-square analysis for categorical variables\niufd, Intrauterine fetal demise; sab, spontaneous Abortion.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 15, '25-OH'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 248, 'Pregnancy'), ('GO_0007128', 'meiotic prophase I', 386, 'Preeclampsia'), ('GO_0007565', 'female pregnancy', 408, 'preterm'), ('GO_0007567', 'parturition', 416, 'deliveries3'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007567', 'parturition', 478, 'delivery'), ('PR_000007939', 'glial fibrillary acidic protein', 504, 'GDM11'), ('GO_0007569', 'cell aging', 619, 'abortion'), ('UBERON_0022293', 'reproductive gland secretion', 659, 'intrauterine'), ('GO_0007565', 'female pregnancy', 697, 'gestational'), ('CHEBI_27300', 'vitamin D', 832, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 870, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 870, 'D'), ('CHEBI_28384', 'vitamin K', 894, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 930, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 930, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1077, 'Gestational'), ('UBERON_0000970', 'eye', 1748, 'Vaginal'), ('UBERON_0022293', 'reproductive gland secretion', 2266, 'intrauterine'), ('GO_0007569', 'cell aging', 2310, 'abortion')]
S132-PMC4405493	PMC4405493	4/2015	S132-PMC4405493	['the Liver converts both forms of Vitamin D to 25-Oh Vitamin D, which is the specific Metabolite measured to determine Vitamin D status.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 46, '25-OH'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 85, 'metabolite'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
S1449-PMC4448820	PMC4448820	5/2015	S1449-PMC4448820	['○ Retinol is Homeostatically Regulated and is not a good indicator of status when there are adequate Liver stores of Vitamin A (770).']	N/A	N/A	[('CHEBI_27810', 'resorcinol', 2, 'Retinol'), ('GO_0048872', 'homeostasis of number of cells', 13, 'homeostatically'), ('GO_0065007', 'biological regulation', 29, 'regulated'), ('UBERON_0002107', 'liver', 101, 'liver'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A')]
S244-PMC4499946	PMC4499946	7/2015	S244-PMC4499946	['subgroup and interaction analyses will be based on the following covariates: ga at Birth, infant sex, maternal baseline Vitamin D status, maternal height, and maternal supplement adherence.']	N/A	N/A	[('GO_0007567', 'parturition', 83, 'birth'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S75-PMC4598849	PMC4598849	10/2015	S75-PMC4598849	['second, 25(Oh)D levels at Birth cannot represent the Vitamin D status in early Pregnancy.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('GO_0007567', 'parturition', 26, 'birth'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy')]
S66-PMC4632418	PMC4632418	10/2015	S66-PMC4632418	['**, adjustments a: age; b: body mass index (bmi); c: ethnicity; d: family history of type 2 diabetes mellitus (t2dm); e: season; f: socio-economic status; g: previous history of gdm; h: Gestational age; i: maternal weight; j: Triglyceride (Tg); k: education; l: marital status; m: smoking; n: Pregnancy weight gain; o: physical activity; p: dietary intake of fish and calcium; q: trimester; r: Vitamin D lifestyle score; s: Parathyroid hormone (pth); t: parity; u: waist circumference; v: Vitamin D intake.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 186, 'gestational'), ('CHEBI_17855', 'triglyceride', 226, 'triglyceride'), ('CHEBI_17855', 'triglyceride', 240, 'TG'), ('GO_0007565', 'female pregnancy', 293, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 394, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 424, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 489, 'vitamin D')]
S31-PMC4645901	PMC4645901	8/2014	S31-PMC4645901	['in such times, Vitamin D status is relied upon dietary intake and body stores.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
S87-PMC4690051	PMC4690051	12/2015	S87-PMC4690051	['median dietary intake of Vitamin D during the second trimester for the whole cohort was 177 iu (range 13.3–772).nutrients-07-05499-t001_table 1\n\ncaption (table-wrap): table 1\n\ncharacteristics of the mothers at enrollment and the children at 2-year assessment (cv2; n = 1020).n %insurance\u2003other insurance48947.9\u2003medicaid, medicare53152.1education\u2003hs diploma or lower56755.6\u2003college or higher degree45344.4marital status\u2003cohabitation60158.9\u2003single41941.1pre-Pregnancy bmi, kg/m2\u2003underweight454.4\u2003normal39738.9\u2003overweight24023.5\u2003obese33833.1alcohol use, yes868.4tobacco use, yes858.3total Pregnancies1\u2003130930.3\u20032–559458.2\u2003>511711.5gestational 25(Oh)D\u2003<20 ng/dl42541.7\u200320.00–29.99 ng/dl44043.1\u2003≥30 ng/dl15515.2 meansd Weeks Of Gestation38.91.725(Oh)D, ng/dl22.38.5maternal age, years26.65.5maternal total iq96.216.4birth weight, z -score0.050.95birth length, z -score0.531.28head circumference, z -score−0.031.34child age at cv2 assessment, months25.01.5cognitive scaled score29.62.6receptive language scaled score29.52.9expressive language scaled score29.92.7\n1includes current Pregnancy and previously completed term and pre-term Pregnancies;2as assessed at 2-year exam (cv2).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 456, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 586, 'Pregnancies1'), ('CHEBI_71657', 'versiconol acetate', 640, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 646, 'D'), ('GO_0016055', 'Wnt signaling pathway', 714, 'Weeks of Gestation38'), ('CHEBI_33010', 'chromide(1-)', 741, '(OH)D'), ('GO_0007565', 'female pregnancy', 1075, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1128, 'pregnancies')]
S100-PMC4690051	PMC4690051	12/2015	S100-PMC4690051	['dietary intake of Vitamin D was not associated with scaled scores or mid-Gestational 25(Oh)D levels.nutrients-07-05499-t002_table 2\n\ncaption (table-wrap): table 2\n\nscaled developmental scores by selective characteristics ( n = 1020).Cognitivereceptive languageexpressive languagemeansd p1meansd p1meansd p1race<0.0001<0.0001<0.0001\u2003african-american8.82.28.62.39.32.3\u2003european-american11.02.711.13.111.03.1insurance<0.0001<0.0001<0.0001\u2003other insurance10.42.810.53.110.73.0\u2003medicaid, medicare8.82.18.62.39.22.2education<0.0001<0.0001<0.0001\u2003hs diploma or lower8.92.18.72.49.32.2\u2003college or higher degree10.42.810.53.110.73.0marital status<0.0001<0.0001<0.0001\u2003cohabitation10.12.710.13.010.32.9\u2003single8.82.28.62.39.32.3pre-Pregnancy bmi, kg/m20.00010.00010.0001\u2003under weight9.72.29.92.99.92.6\u2003normal9.92.79.93.110.42.9\u2003overweight9.52.39.42.710.02.6\u2003obese9.22.69.02.79.42.4alcohol use0.00240.0020.007\u2003no9.52.59.42.89.82.6\u2003yes10.33.010.73.610.63.1tobacco use<0.0006<0.0006<0.0006\u2003no9.62.69.62.910.02.7\u2003yes8.72.08.52.78.82.6total Pregnancies0.00060.0290.0028\u2003110.02.99.83.010.32.7\u20032–59.52.49.52.99.82.8\u2003>58.82.28.82.39.42.2gestational diabetes0.100.220.14\u2003missing8.32.19.72.59.71.2\u2003no9.52.69.52.99.92.7\u2003yes10.02.69.93.010.32.9pre-eclampsia0.0670.0230.19\u2003missing9.02.29.62.59.81.6\u2003no9.62.69.62.910.02.7\u2003yes9.12.28.82.49.52.6delivery0.00210.1020.024\u2003pre-term8.82.28.92.99.32.8\u2003full term9.62.69.52.910.02.7gestational 25(oh)d<0.0001<0.0001<0.0001\u2003<20 ng/dl9.12.48.92.59.42.4\u200320.00–29.99 ng/dl9.82.89.73.010.22.9\u2003≥30 ng/dl10.12.410.53.210.42.6\n1p -value for comparison among the subgroups ( i.e.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 85, '25 ... OH ... D'), ('GO_0050802', 'circadian sleep/wake cycle, sleep', 233, 'CognitiveReceptive'), ('GO_0007565', 'female pregnancy', 721, 'Pregnancy'), ('GO_0006412', 'translation', 1025, 'Pregnancies0'), ('CHEBI_37972', 'phosphorus-32 atom', 1410, '25')]
S42-PMC4811441	PMC4811441	3/2016	S42-PMC4811441	['during these periods, chosen to capture the seasonality of Vitamin D status, all Pregnant women registering at the Antenatal Care within the study areas were eligible for inclusion.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('GO_0007608', 'sensory perception of smell', 115, 'antenatal care')]
S88-PMC4811441	PMC4811441	3/2016	S88-PMC4811441	['in model 2, Vitamin D status was fixed and only baseline 25(Oh)D was included.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 63, 'D')]
S48-PMC4859539	PMC4859539	5/2016	S48-PMC4859539	['using the institute of medicine’s definition of sufficiency (total circulating 25(Oh)D ≥20 ng/ml (50 nmol/l) [25], the cohort also was divided into two groups based on child’s current Vitamin D status, with those with 25(Oh)D concentrations <20 ng/ml (50.0 nmol/l) defined as deficient.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 79, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 218, '25(OH)D')]
S57-PMC4859539	PMC4859539	5/2016	S57-PMC4859539	"[""of infections in the last year [median (range)]1.0 (0.0–5.0)child’s daily Vitamin D intake at time of visit (iu/day)1205.3 ± 109.8 (17.1–512.5)child's 25(Oh)D at time of visit (ng/ml)127.2 ± 9.4 (8.3–61.5)child's Vitamin D status at time of visit\xa0\xa0\xa0\xa0\xa0sufficient (≥20 ng/ml) [n (%)]106 (79.7)\xa0\xa0\xa0\xa0deficient (<20 ng/ml) [n (%)]27 (20.3)total circulating 25(Oh)D (ng/ml) at Birth122.8 ± 9.8 (3.6–47.8)maternal 25(Oh)D (ng/ml) within 1 month prior to Delivery139.2 ± 15.0 (10.0–78.6)maternal 25(Oh)D area under curve, Pregnancy visits 3–71153.1 ± 44.6 (50.1–251.4)\n1mean±std (range)\n\nstudy outcomes\nthe median Cathelicidin concentration for the entire cohort was 28.1 ng/ml, ranging from 5.6 to 3368.6 ng/ml.""]"	N/A	N/A	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 154, 'OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 157, 'D'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 351, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 351, '25 ... OH ... D'), ('GO_0042750', 'hibernation', 370, 'birth122'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 406, '25(OH)D'), ('GO_0030324', 'lung development', 446, 'delivery139'), ('CHEBI_71657', 'versiconol acetate', 487, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 487, '25(OH)D'), ('GO_0007565', 'female pregnancy', 513, 'pregnancy'), ('CHEBI_3364', 'Canthiumine', 605, 'cathelicidin')]
S80-PMC4859539	PMC4859539	5/2016	S80-PMC4859539	['when dividing the cohort by Vitamin D sufficiency status for additional analyses, Vitamin D deficiency was defined as <20 ng/ml (<50 nmol/l)).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S8-PMC4889866	PMC4889866	5/2016	S8-PMC4889866	['there was no relationship between maternal and Cord Blood Vitamin D status with infectious diseases during infancy.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 47, 'cord'), ('UBERON_0000178', 'blood', 52, 'blood'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S163-PMC4891833	PMC4891833	6/2016	S163-PMC4891833	['in Serum samples collected at endline, ferritin and Transferrin Receptor as markers of iron status, Retinol Binding Protein as a marker of Vitamin A status, and c-Reactive Protein (Crp) and Alpha-1 Acid Glycoprotein (agp) as markers of inflammation will be measured.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 3, 'serum'), ('PR_000001679', 'trace amine-associated receptor 5', 52, 'transferrin receptor'), ('CHEBI_26536', 'retinoic acid', 100, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 100, 'retinol binding protein'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 163, 'reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 181, 'CRP'), ('PR_000001183', 'alpha-1A adrenergic receptor', 190, 'alpha-1 acid glycoprotein'), ('CHEBI_15369', 'actinomycin', 198, 'acid glycoprotein')]
S1249-PMC4896250	PMC4896250	4/2016	S1249-PMC4896250	['concluson: foki vdr polymorphism determine Vitamin D status in children with Food allergy.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_33290', 'food', 77, 'food')]
S54-PMC4929134	PMC4929134	8/2016	S54-PMC4929134	['Plasma concentrations of Retinol, 25(Oh)D, cobalamin, Folic Acid, Transferrin receptor, ferritin, and thyroglobulin were measured to assess child Vitamin A, d, and b12, Folate, iron, and Iodine status.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_26536', 'retinoic acid', 25, 'retinol'), ('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('CHEBI_30751', 'formic acid', 54, 'folic acid'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 66, 'transferrin'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 169, 'folate'), ('CHEBI_24859', 'iodine atom', 187, 'iodine')]
S61-PMC4930210	PMC4930210	7/2016	S61-PMC4930210	['measurement of Vitamin D status\nmaternal Blood was collected at each clinic visit by a certified phlebotomist.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0000178', 'blood', 41, 'blood')]
S51-PMC4944244	PMC4944244	7/2016	S51-PMC4944244	['the questionnaire included age, gender, ethnicity, smoking, educational status, Antenatal history, previous medical, surgical, obstetrics and gynecology history, sun protection score, length of time exposed to sunlight (minutes per week) and ffq Vitamin D/my.']	N/A	N/A	[('GO_0007567', 'parturition', 80, 'antenatal'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
S83-PMC4944244	PMC4944244	7/2016	S83-PMC4944244	['caption (table-wrap): table 3\n\ncombination of descriptive and simple logistic regression analysis to show the relationship between risk factors and hypovitaminosis d ( n \u2009=\u2009396)variableserum 25(Oh)D <50\xa0nmol/l n\u2009(%) mean\u2009±\u2009sd median (iqr)Serum 25(Oh)D ≥50\xa0nmol/l n\u2009(%) mean\u2009±\u2009sd median (iqr)crude or (95 % ci) p valueage(year)c27.91\u2009±\u20093.9529.47\u2009±\u20095.070.91(0.84, 0.99)0.026ethnic groupscmalay296 (96.40)11 (3.60)22.42(9.63, 52.21)<0.001chinese24 (54.50)20 (45.5)1.00indian32 (91.40)3 (8.60)8.89(2.36, 33.40)0.001others6 (60.00)4 (40.00)1.25(0.31, 5.06)0.754education levelcprimary11 (68.80)5 (31.20)1.00secondary136 (91.30)13 (8.70)4.75(1.43, 15.80)0.011tertiary211 (91.30)20 (8.70)4.80(1.52, 15.18)0.008working statusworking275 (91.40)26 (8.60)1.000.252not working83 (87.40)12 (12.60)0.65(0.32, 1.35)household income per monthc3500 (2800,5000)3750 (2500,5250)1.00(1.00, 1.00)0.060household Membersc3 (2,4)3 (2,5)0.90(0.75, 1.07)0.225weeks of Pregnancy at first Antenatal visitc10.0 (8.0,12.0)11.5 (8.0,12.0)0.89(0.77,1.02)0.100parityc0 (0,1)1 (0,1)0.79(0.61, 1.03)0.083last child Birth≤ 2\xa0years111 (89.50)13 (10.50)0.86(0.43,1.75)0.686>2 yearsa247 (90.80)25 (9.20)1.00breastfeedingyes36 (87.80)5 (12.20)0.74(0.27,2.01)0.552nob322 (90.70)33 (9.30)1.00bmi before Pregnant (kg/m2)22.76 (20.00,26.25)22.15 (19.75,26.58)1.02(0.96,1.09)0.499weight at first Antenatal visit (Kg)57.85 (49.30,68.54)57.03 (51.49,65.61)1.01(0.98,1.03)0.569fitzpatrick classificationcskin type i-ii83 (80.60)20 (19.40)1.00skin type iii163 (94.20)10 (5.80)3.93(1.76,8.77)0.001skin type iv-vi112 (93.30)8 (6.70)3.37(1.42,8.03)0.006melanin indices (using mexameter)(0-999.000)306.17 (254.17,373.67)242.83 (181.08, 354.00)1.01(1.00,1.01)0.006sun protection score(0-8)c5 (4,5)3.5 (1,5)1.77(1.42,2.21)<0.001total of respondents exposed to sunlight (10\xa0am-2\xa0pm)yes201 (90.10)22 (9.90)1.00no157 (90.80)16 (9.20)1.07(0.55,2.11)0.836the length of time exposed to sunlight (minutes in week)35 (0,150)55 (0,210)1.00(1.00,1.00)0.570intake of Vitamin D from Food (iu/day)c197.51 (122.70,332.05)263.81 (142.90,460.55)1.00(1.00,1.00)0.042intake of Vitamin D from Food and supplements (iu/day)215.080 (132.93,361.98)302.135 (147.89,515.74)1.00(1.00,1.00)0.064the level of Vitamin D in Foods and supplements (iu/day)<200\xa0iu/day165 (92.70)13 (7.30)1.64(0.82,3.32)0.165≥200\xa0iu/day193 (88.50)25 (11.50)1.00\nor odds ratio, ci confidence interval\np values have been derived from wald tests\narespondents with last child Birth more than 2\xa0years and respondents who did not have previous child (primid)\nbrespondents who did not Breastfeed during Pregnancy and those who did not have children.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 191, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 194, 'OH ... D'), ('UBERON_0001977', 'blood serum', 238, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 244, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 247, 'OH ... D'), ('PR_000010433', 'makorin-3', 890, 'membersc3'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('GO_0007567', 'parturition', 961, 'antenatal'), ('GO_0007567', 'parturition', 1080, 'birth'), ('GO_0007565', 'female pregnancy', 1261, 'pregnant'), ('GO_0007567', 'parturition', 1351, 'antenatal'), ('UBERON_0001465', 'knee', 1368, 'kg'), ('CHEBI_27300', 'vitamin D', 2001, 'vitamin D'), ('CHEBI_33290', 'food', 2016, 'food'), ('CHEBI_27300', 'vitamin D', 2104, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 2112, 'D'), ('CHEBI_33290', 'food', 2119, 'food'), ('CHEBI_27300', 'vitamin D', 2227, 'vitamin D'), ('CHEBI_33290', 'food', 2240, 'foods'), ('GO_0007567', 'parturition', 2468, 'birth'), ('GO_0007596', 'blood coagulation', 2574, 'breastfeed'), ('GO_0007565', 'female pregnancy', 2592, 'pregnancy')]
S182-PMC4944244	PMC4944244	7/2016	S182-PMC4944244	['none of the Antenatal history associated with Vitamin D status.']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'antenatal'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S2-PMC4973215	PMC4973215	8/2016	S2-PMC4973215	['multivariable logistic regression models were used to evaluate associations between maternal characteristics, Vitamin D status and sga.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S36-PMC4973215	PMC4973215	8/2016	S36-PMC4973215	['results\nof the 506 non-hispanic white and black infants, 438 with available data on Vitamin D status, bmi at Delivery, Prenatal Vitamin use and pre-eclampsia/Pregnancy-induced hypertension (pih) history were included in final analyses.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007567', 'parturition', 109, 'delivery'), ('GO_0007565', 'female pregnancy', 119, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 128, 'vitamin'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
S44-PMC4973215	PMC4973215	8/2016	S44-PMC4973215	['after adjusting for medicaid status, bmi at Delivery and Prenatal vitamin use, black infants had a 3.6 greater odds (95% confidence interval (ci): 2.4, 5.6) of having Vitamin D deficiency compared with white infants (table 2).']	N/A	N/A	[('GO_0007567', 'parturition', 44, 'delivery'), ('GO_0007565', 'female pregnancy', 57, 'prenatal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
S4-PMC4982007	PMC4982007	8/2016	S4-PMC4982007	['methods\nexposures considered were maternal bmi, height and weight, Micronutrient status (Vitamins D, B12, Folate and iron) and Macronutrient intakes (Carbohydrate, protein and fat).']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 89, 'vitamins D'), ('CHEBI_27778', 'abequose', 101, 'B12'), ('CHEBI_30863', '5-azaorotic acid', 106, 'folate'), ('CHEBI_33937', 'macronutrient', 127, 'macronutrient'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 150, 'carbohydrate')]
S42-PMC4982007	PMC4982007	8/2016	S42-PMC4982007	['eligibility criteria, search strategy and identification of literature\nour exposure of interest was maternal nutritional status during Pregnancy: bmi, height and weight; status or intake of selected single Micronutrients (Vitamins D, b1, b6, b12 and Folate) and iron and dietary intake of Macronutrients (Carbohydrate, protein and fat).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 206, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 222, 'vitamins D'), ('CHEBI_30863', '5-azaorotic acid', 250, 'folate'), ('CHEBI_33839', 'macromolecule', 289, 'macronutrients'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 305, 'carbohydrate')]
S47-PMC4982007	PMC4982007	8/2016	S47-PMC4982007	['caption (table-wrap): table 1\n\nlist of mesh terms and the text word terms used for exposure and outcomeexposure: maternal nutritional status during Pregnancyoutcome: childhood and adolescent Cognitive functionmesh termstext word termsmesh termstext word terms“exp body weight/or exp body mass index/or exp anthropometry/or exp body size/or exp Skinfold thickness/or exp nutrition assessment/or exp nutritional status/or exp mothers/or exp Pregnancy/or exp malnutrition/or exp diet vegetarian/or exp haemoglobin/or Pregnancy complications/or exp anemia/or exp Folic Acid/or exp Folic Acid deficiency/or exp Vitamin B12 deficiency/or exp ferritin/or exp iron, dietary/or exp Cholecalciferol/or exp Pyridoxine/or exp Vitamin B Complex/or exp riboflavin/or exp Thiamine/or exp Vitamin D/”“maternal nutrition or maternal anthropometry or Pregnancy nutrition or Antenatal nutrition or intrauterine nutrition or Gestational nutrition or maternal undernutrition or Prenatal nutrition or maternal bmi or maternal Micronutrients or vegan mothers or vegetarian mothers or Macrobiotic mothers or maternal Folate or maternal Folic Acid or maternal Vitamin B12 or maternal cobalamin or maternal Vitamin D or 25 Hydoxy Vitamin D or maternal Cholecaliciferol or maternal haemoglobin or maternal iron or maternal b Vitamins or maternal vitamin b1 or maternal vitamin b6 or maternal Vitamin B9 or maternal b Vitamins or maternal anaemia or maternal diet”“exp child/or exp Child Development/or exp adolescent/or exp neurobehavioral manifestations/or exp child, preschool/or exp Cognition, physiology/or exp attention/or exp Memory, Long-Term/or exp Memory, short-term/or exp Memory/or exp intelligence tests/or exp psycho motor performance/or exp child psychology/or exp Decision Making/or exp psychometrics/or exp intelligence/or exp mental competence/or exp Cognition/or exp motor skills/or exp Language Development/or exp Learning/or exp Verbal Learning/or exp Problem Solving/or exp perception/or exp Thinking/or exp executive function/or exp function/or exp Human development/or exp adolescent development/or exp speech/or exp mental Processes/Cognitive function or intelligence or iq or executive function or Psychomotor Development or cognitive performance or Cognition or educational attainment or Cognitive ability or Cognitive deficits or intellectual ability or Learning or Memory or Language Development.']	N/A	N/A	[('GO_0006606', 'protein import into nucleus', 148, 'pregnancyOutcome'), ('GO_0050890', 'cognition', 191, 'cognitive'), ('UBERON_0009007', 'superficial inguinal lymph node', 344, 'skinfold'), ('GO_0007565', 'female pregnancy', 439, 'pregnancy'), ('GO_0007565', 'female pregnancy', 514, 'pregnancy'), ('CHEBI_30751', 'formic acid', 559, 'folic acid'), ('CHEBI_30751', 'formic acid', 577, 'folic acid'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 606, 'vitamin b12'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 606, 'vitamin b12'), ('CHEBI_52550', 'theopalauamide', 673, 'cholecalciferol'), ('CHEBI_16410', 'pyridoxamine', 696, 'pyridoxine'), ('CHEBI_49976', 'zinc dichloride', 714, 'vitamin b'), ('GO_0032991', 'protein-containing complex', 724, 'complex'), ('CHEBI_26948', 'vitamin B1', 757, 'thiamine'), ('CHEBI_27300', 'vitamin D', 773, 'vitamin D'), ('GO_0007565', 'female pregnancy', 833, 'pregnancy'), ('GO_0007567', 'parturition', 856, 'antenatal'), ('GO_0007565', 'female pregnancy', 905, 'gestational'), ('GO_0007565', 'female pregnancy', 957, 'prenatal'), ('CHEBI_33839', 'macromolecule', 1004, 'micronutrients'), ('CHEBI_64709', 'organic acid', 1061, 'macrobiotic'), ('CHEBI_30863', '5-azaorotic acid', 1093, 'folate'), ('CHEBI_30751', 'formic acid', 1112, 'folic acid'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 1135, 'vitamin b12'), ('PR_000004677', 'breast cancer anti-estrogen resistance protein 3', 1143, 'b12'), ('CHEBI_27300', 'vitamin D', 1181, 'vitamin D'), ('CHEBI_45557', 'sec-butyl group', 1194, '25 hydoxy'), ('CHEBI_27300', 'vitamin D', 1204, 'vitamin D'), ('CHEBI_17937', 'L-rhamnono-1,4-lactone', 1226, 'cholecaliciferol'), ('CHEBI_33277', 'gamma-tocotrienol', 1298, 'vitamins'), ('CHEBI_33229', 'vitamin (role)', 1365, 'vitamin'), ('PR_000017209', 'utrophin', 1365, 'vitamin b9'), ('CHEBI_33277', 'gamma-tocotrienol', 1390, 'vitamins'), ('GO_0001410', 'chlamydospore formation', 1454, 'child development'), ('GO_0050890', 'cognition', 1559, 'cognition'), ('GO_0007613', 'memory', 1605, 'memory'), ('GO_0007616', 'long-term memory', 1613, 'long-term'), ('GO_0007613', 'memory', 1630, 'memory'), ('GO_0007613', 'memory', 1656, 'memory'), ('GO_0016045', 'detection of bacterium', 1752, 'decision making'), ('GO_0050890', 'cognition', 1841, 'cognition'), ('GO_0060132', 'prolactin secreting cell development', 1878, 'language development'), ('GO_0007612', 'learning', 1906, 'learning'), ('GO_0008355', 'olfactory learning', 1922, 'verbal learning'), ('GO_0008283', 'cell proliferation', 1945, 'problem solving'), ('GO_0007596', 'blood coagulation', 1986, 'thinking'), ('NCBITaxon_9606', 'Homo sapiens', 2044, 'human'), ('GO_0007565', 'female pregnancy', 2120, 'processes'), ('GO_0050890', 'cognition', 2130, 'Cognitive'), ('GO_0030324', 'lung development', 2196, 'psychomotor development'), ('GO_0050890', 'cognition', 2248, 'cognition'), ('GO_0050890', 'cognition', 2287, 'cognitive'), ('GO_0050890', 'cognition', 2308, 'cognitive'), ('GO_0007612', 'learning', 2354, 'learning'), ('GO_0007613', 'memory', 2366, 'memory'), ('GO_0060132', 'prolactin secreting cell development', 2376, 'language development')]
S272-PMC4982007	PMC4982007	8/2016	S272-PMC4982007	['for example children of mothers with normal Vitamin D status scored 0.1-0.2 sd higher in Mental and Psychomotor Development tests compared to children of deficient mothers [22].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007613', 'memory', 89, 'mental ...'), ('GO_0030324', 'lung development', 100, 'psychomotor development')]
S301-PMC4990268	PMC4990268	8/2016	S301-PMC4990268	['evidence: the first cluster randomized rct was done in a population in rural, southern nepal with a high prevalence of low Vitamin A-intake and poor Vitamin a status[105].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 123, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 149, 'vitamin')]
S28-PMC4997421	PMC4997421	8/2016	S28-PMC4997421	['outcomes: the main outcome variable was Vitamin A status as assessed by Serum Retinol concentrations.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('UBERON_0001977', 'blood serum', 72, 'serum'), ('CHEBI_26536', 'retinoic acid', 78, 'retinol')]
S31-PMC4997421	PMC4997421	8/2016	S31-PMC4997421	['for the multivariate models, we dichotomized Vitamin A status into insufficient (<1.05) and sufficient (>1.05).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
S80-PMC4997421	PMC4997421	8/2016	S80-PMC4997421	['the proportion of Individuals who were Vitamin A deficient or insufficient increased as poverty status increased (table 2).']	N/A	N/A	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A')]
S192-PMC5024513	PMC5024513	9/2016	S192-PMC5024513	['intake of Vitamin D and Serum Selenium status were identified as being significantly low in pooled analysis of included studies.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_27568', 'selenium atom', 30, 'selenium')]
S47-PMC5029029	PMC5029029	9/2016	S47-PMC5029029	['in addition to the biochemical tests (targeted at ckd), we progressively added iron status, B12, and 25-Oh Vitamin D to the routine monthly tests; Vitamins and iron supplements were employed on the basis of the biochemical results.']	N/A	N/A	[('CHEBI_27778', 'abequose', 92, 'B12'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 101, '25-OH'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 147, 'vitamins')]
S49-PMC5039809	PMC5039809	10/2016	S49-PMC5039809	['maternal Vitamin D status was determined from Serum 25-Hydroxyvitamin D concentrations.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0001977', 'blood serum', 46, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 52, '25-hydroxyvitamin D')]
S27-PMC5045784	PMC5045784	10/2016	S27-PMC5045784	['we measured 25(Oh)D levels, a combination of 25(Oh)D2And 25(Oh)D3, which represent the best analytes for overall Vitamin D status11using diasorin liaison (diasorin, stillwater, mn, usa), which uses a chemiluminescence immunoassay12to determine Plasma concentrations of 25(Oh)D. for quality control, the laboratory used the us national institute of standards and technology level 1.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 12, '25(OH)D'), ('CHEBI_76948', 'ent-manool', 45, '25(OH)D2and'), ('CHEBI_62946', 'ammonium sulfate', 57, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 244, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 271, '(OH ... D')]
S15-PMC5084041	PMC5084041	10/2016	S15-PMC5084041	['one of these areas of interest is Vitamin D status during Pregnancy.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy')]
S16-PMC5084041	PMC5084041	10/2016	S16-PMC5084041	['the Pregnant woman’s Vitamin D status determines the Vitamin D status of her newborn infant [1].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 4, 'pregnant'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
S34-PMC5084041	PMC5084041	10/2016	S34-PMC5084041	['determinants of Vitamin D deficiency in the first trimester of Pregnancy and of changes in Vitamin D status during Pregnancy were identified.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
S65-PMC5084041	PMC5084041	10/2016	S65-PMC5084041	['the 25(Oh)D concentration was adjusted to the predicted yearly mean 25(Oh)D of the function, in order to account for seasonality in Vitamin D status.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
S2-PMC5146866	PMC5146866	12/2016	S2-PMC5146866	['methods\namerican academy of pediatrics (aap) defined levels (ng/ml) were utilized to categorize the Vitamin D status in cb samples as deficient (5–15), insufficient (16–20), and sufficient (21–100).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
S8-PMC5146866	PMC5146866	12/2016	S8-PMC5146866	['we did not find an association between the Vitamin D status at Birth and pre-discharge clinical characteristics of the neonates.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'birth')]
S57-PMC5146866	PMC5146866	12/2016	S57-PMC5146866	['characteristics of Umbilical Cord Blood Vitamin D status\ncb levels of Vitamin D were classified as deficient, insufficient, and sufficient in 95 (38.9%, 95%ci 33.0–44.8), 79 (29.8%, 95%ci 24.3–35.3), and 91 (34.3%, 95%ci 28.6–40) infants, respectively.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 19, 'umbilical cord'), ('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
S63-PMC5146866	PMC5146866	12/2016	S63-PMC5146866	['caption (table-wrap): table 1\n\nmaternal demographics and clinical characteristics with respect to cb Vitamin D statusparametricvitamin D status p valuedeficiency n \u2009=\u200995insufficiency n \u2009=\u200979sufficiency n \u2009=\u200991age (years)30.6+/−5.7(29.4–31.8)29.9+/−5.1(28.8–31.1)32.6+/−5.3(31.5–33.8)<0.01medicaid/uninsured16.0%(9.9–24.7)8.8%(4.3–16.9)6.7%(3.1–13.6)0.09weight at Birth (pounds)175+/−41(167–183)172+/−34(165–180)174+/−39(166–182)0.89multiple Gestation1.1%(0.002–0.06)1.3%(0.002–0.07)3.3%(0.11–0.09)0.47nulliparity (%)27.7%(19.6–37.4)38.8%(28.8–49.7)36.3%(27.1–46.5)0.26first gravidity (%)21.3%(9.1–23.5)26.3%(14.7–32.8)31.9%(6.9–20.4)0.56gravidity (number)3.4+/−2.4(2.9–3.9)2.8+/−1.9(2.3–3.2)2.4+/−1.3(2.1–2.6)<0.01gestational age38.9+/−1.3(38.6–39.1)39.2+/−1.2(38.9–39.5)39.0+/−1.3(38.7–39.3)0.15winter season Deliveries14.9%(9.1–23.5)22.5%(14.7–32.8)12.1%(6.9–20.4)0.17cesarean section32.9%(24.3–42.9)35.0%(25.5–45.9)41.8%(32.2–52.1)0.44vitamins supplementation66.0%(60.3–78.5)77.5%(67.2–85.3)67.0%(56.9–75.8)0.20iron supplementation8.5%(4.4–15.9)3.8%(1.3–10.5)2.2%(0.6–7.7)0.15thyroid medications9.6%(5.1–17.2)8.8%(4.3–16.9)8.8%(4.5–16.4)0.98substance abuse (smoking/alcohol/Drugs)3.2%(1.1–8.9)5.0%(2.0–12.2)6.6%(3.1–13.6)0.56morbidities during Pregnancy21.3%(14.2–30.6)26.3%(17.9–36.8)23.1%(15.6–32.7)0.74diabetes10.6%(5.9–18.5)12.5%(6.9–21.5)7.7%(3.8–15.1)0.57\ndata presented as mean or proportion (%) with 95% confidence interval\n\ncaption (fig): fig.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('GO_0007567', 'parturition', 363, 'birth'), ('GO_0007565', 'female pregnancy', 441, 'gestation1'), ('GO_0060179', 'male mating behavior', 810, 'deliveries14'), ('CHEBI_23888', 'drug', 1177, 'drugs'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy21')]
S65-PMC5146866	PMC5146866	12/2016	S65-PMC5146866	['chi-square test statistics were used to compare cb vitamin status defined as deficient, insufficient and sufficient with respect to maternal race/ethnicity\n\nfactors associated with cb Vitamin D status\nmaternal race/ethnicity, age and gravidity were included in the multiple regression models to identify factors associated with detection of Vitamin D deficiency (model 1) and insufficiency (model 2) in infants’ cb.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D')]
S71-PMC5146866	PMC5146866	12/2016	S71-PMC5146866	['caption (table-wrap): table 2\n\ncontribution of maternal characteristics in development of cb Vitamin D deficiency and insufficiencyvariablescb Vitamin D statusinsufficiencydeficiencyβ +/−std.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
S75-PMC5146866	PMC5146866	12/2016	S75-PMC5146866	['cb Vitamin D status: deficiency ( n \u2009=\u200995), insufficiency ( n \u2009=\u200979), sufficient ( n \u2009=\u200991)\n\nneonatal characteristics and cb Vitamin D status\namong the 265 infants in this study, 6.4% were Born at Gestational age between 37 and 34\xa0weeks and 1.9% from multiple Gestations.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('GO_0007567', 'parturition', 189, 'born'), ('GO_0007565', 'female pregnancy', 197, 'gestational'), ('GO_0007565', 'female pregnancy', 260, 'gestations')]
S54-PMC5155676	PMC5155676	12/2016	S54-PMC5155676	['the cut-point of 50 nmol/l as the definition for Vitamin D replete status was chosen to reflect the iom guidelines (5).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
S68-PMC5155676	PMC5155676	12/2016	S68-PMC5155676	['maternal characteristics at baseline according to randomization groupplacebo1000-iu/d Cholecalciferoln422407Gestation (wk), mean (sd)15.9 (1.5)15.9 (1.5)maternal age (y), mean (sd)30.7 (5.4)30.7 (5.0)nulliparous (%)44.842.7current smoker (%)7.77.7bmi (kg/m2), median (iqr)25.4 (22.7–29.7)24.6 (22.2–28.6)height (cm), mean (sd)165.6 (6.6)165.5 (6.3)white ethnicity (%)94.895.625(Oh)D (nmol/l), median (iqr)44.4 (33.2–57.0)45.7 (34.3–57.8)\n\nmaternal 25(Oh)D status at 34 weeks of Gestation by randomization group\nmaternal 25(Oh)D at 34 weeks of Gestation was greater in the women randomized to Cholecalciferol (mean 67.7 nmol/l [sd 21.3 nmol/l]) compared with the placebo group (mean 43.1 nmol/l [sd 22.5 nmol/l], p< .0001); 83.3% of women randomized to Cholecalciferol achieved Vitamin D replete status at 34 weeks of Gestation (>50 nmol/l) compared with 35.6% in the placebo group ( p< .001).']	N/A	N/A	[('CHEBI_52815', 'cresyl violet', 86, 'Cholecalciferoln422407Gestation'), ('CHEBI_33010', 'chromide(1-)', 377, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 451, 'OH)D'), ('GO_0007565', 'female pregnancy', 478, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 520, '25(OH)D'), ('GO_0007565', 'female pregnancy', 543, 'gestation'), ('CHEBI_52550', 'theopalauamide', 592, 'cholecalciferol'), ('CHEBI_52550', 'theopalauamide', 752, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('GO_0007565', 'female pregnancy', 817, 'gestation')]
S58-PMC5318550	PMC5318550	2/2017	S58-PMC5318550	['these sd scores were constructed based on distributions in the generation r cohort.17\n\nassessment of Vitamin D status in maternal mid-Pregnancy and Cord Blood Plasma samples\ntotal Vitamin D was reported as the sum of 25-Hydroxyvitamin D2 (25ohd2) and 25-Hydroxyvitamin D3 (25ohd3) species measured in maternal Plasma and Cord Blood samples using a modification of a method previously described.18in mid-Pregnancy (mean 20.6\u2005weeks; sd 1.0, iqr 1.14), Venous Blood samples were collected and directly after Delivery (mean Gestational duration 39.8\u2005weeks; sd 1.8, iqr 2.0), midwives or obstetricians collected Cord Blood from the Umbilical Vein.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0000178', 'blood', 153, 'blood'), ('UBERON_0001969', 'blood plasma', 159, 'plasma'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_86319', '25-hydroxyvitamin D2', 217, '25-hydroxyvitamin D2'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 235, 'D2'), ('CHEBI_63991', '15-epi-lipoxin B4', 251, '25-hydroxyvitamin D3'), ('UBERON_0001969', 'blood plasma', 310, 'plasma'), ('UBERON_0002240', 'spinal cord', 321, 'cord'), ('UBERON_0000178', 'blood', 326, 'blood'), ('GO_0007565', 'female pregnancy', 403, 'pregnancy'), ('UBERON_0001638', 'vein', 450, 'venous'), ('UBERON_0000178', 'blood', 457, 'blood'), ('GO_0007567', 'parturition', 505, 'delivery'), ('GO_0007565', 'female pregnancy', 520, 'gestational'), ('UBERON_0002240', 'spinal cord', 607, 'cord'), ('UBERON_0000178', 'blood', 612, 'blood'), ('UBERON_0002066', 'umbilical vein', 627, 'umbilical vein')]
S135-PMC5318550	PMC5318550	2/2017	S135-PMC5318550	['we did not observe a meaningful effect of maternal nutritional intake, Vitamin D status or maternal exposure to fever during Pregnancy on the association between child season of Birth and iq.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy'), ('GO_0007567', 'parturition', 178, 'birth')]
S88-PMC5385921	PMC5385921	4/2017	S88-PMC5385921	['in total, 4334 children and their mothers were available with measures of Vitamin D concentrations drawn from maternal Blood at mid-Gestation or drawn from Cord Blood at time of Birth as well as data on the srs and asd status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0000178', 'blood', 119, 'blood'), ('GO_0007565', 'female pregnancy', 132, 'gestation'), ('UBERON_0002240', 'spinal cord', 156, 'cord'), ('UBERON_0000178', 'blood', 161, 'blood'), ('GO_0007567', 'parturition', 178, 'birth')]
S74-PMC5418719	PMC5418719	5/2017	S74-PMC5418719	['after the Vitamin D supplementation, the Serum 25(Oh)D status at discharge in the two groups converged into increasing 25(Oh)D concentrations.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D')]
S91-PMC5452160	PMC5452160	4/2017	S91-PMC5452160	['marginal Vitamin A status was defined as rbp < 1.32 µmol/l [31].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
S48-PMC5489519	PMC5489519	6/2017	S48-PMC5489519	['Serum samples collected from fifteen nursing mothers’ were measured for 25(Oh)D levels to evaluate Vitamin D status in mother groups as described in methods.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 78, 'D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
S23-PMC5521778	PMC5521778	7/2017	S23-PMC5521778	['neonatal or Antenatal Vitamin A supplementation either for preterm infants or Vitamin A deficient Pregnant women improves Vitamin A status and Pulmonary function and mitigates chronic Lung disease [16,17].']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'antenatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin A'), ('GO_0007565', 'female pregnancy', 98, 'pregnant'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0002048', 'lung', 143, 'pulmonary'), ('UBERON_0002048', 'lung', 184, 'lung')]
S33-PMC5524288	PMC5524288	7/2017	S33-PMC5524288	['additionally, obstetrical health care providers received education regarding the potential health impact of low Vitamin D status via continuing medical education (cme) and nurses provided Vitamin D education and standard recommendations for improving Vitamin D status using supplements to obstetrical (ob) patients at the initial visit.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
S80-PMC5634602	PMC5634602	10/2017	S80-PMC5634602	['no significant trends were associated with season of Birth or with pth level (measured at 4 and 8 weeks) at any study time point.10.1371/journal.pone.0185950.t004\n\ncaption (table-wrap): table 4\nweekly dietary Vitamin D intake by group.Vitamin D intakeiu/day400 iu800 iup-valuenmedianiqrnmedianiqr week 1 16233116161261170.046 week 2 16267109162891960.75 week 3 16327154163511420.99 week 4 16357186163291900.64 week 5 15399244143132660.44 week 6 14455174102452200.11 week 7 114122919238950.04 week 8 938035073391340.17\n\nresults for infants <1200 grams at Birth\nas some of the smallest and youngest patients to be enrolled in a Vitamin D trial, infants in the study <1200 grams at Birth were evaluated for 25(Oh)D3Status and response to supplementation regardless of supplementation group, and compared to the larger infants in the study.']	N/A	N/A	[('GO_0007567', 'parturition', 53, 'birth'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 235, 'Vitamin D'), ('GO_0007567', 'parturition', 554, 'birth'), ('CHEBI_27300', 'vitamin D', 626, 'vitamin D'), ('GO_0007567', 'parturition', 679, 'birth'), ('CHEBI_77726', '1-decanoyl-sn-glycero-3-phosphocholine', 704, '25(OH)D3status'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 710, 'D3status')]
S82-PMC5634602	PMC5634602	10/2017	S82-PMC5634602	['our group of preterm infants at Birth had suboptimal Vitamin D status with the median of both groups demonstrating levels below 75 nmol/l.']	N/A	N/A	[('GO_0007567', 'parturition', 32, 'birth'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
S138-PMC5634602	PMC5634602	10/2017	S138-PMC5634602	['conclusions\nadministration of 400 or 800 iu of Vitamin D3Improves Vitamin D status at 4 weeks as compared to Cord levers in high risk infants <32 weeks ega at Delivery.']	N/A	N/A	[('CHEBI_16094', 'thiosulfate(2-)', 47, 'vitamin D3improves'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 47, 'vitamin D3improves'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 109, 'cord'), ('GO_0007567', 'parturition', 159, 'delivery')]
S4-PMC5685050	PMC5685050	10/2014	S4-PMC5685050	"[""Vitamin D2(Ergocalciferol), from dietary sources or supplements, and Vitamin D3Are Metabolized in the Liver to 25-Hydroxyvitamin D (25(Oh)D), which is the major circulating form of Vitamin D and is used to determine an Individual's Vitamin D status[1].""]"	N/A	N/A	"[('CHEBI_28934', 'vitamin D2', 0, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin D2'), ('CHEBI_4910', 'etomidate', 11, 'ergocalciferol'), ('CHEBI_66036', ""(2S)-2'-hydroxy-7,8,3',4',5'-pentamethoxyflavan"", 69, 'vitamin D3are'), ('PR_000017209', 'utrophin', 69, 'vitamin D3are'), ('GO_0008152', 'metabolic process', 83, 'metabolized'), ('UBERON_0002107', 'liver', 102, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 111, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('NCBITaxon_1', 'root', 219, 'individual'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]"
S15-PMC5685050	PMC5685050	10/2014	S15-PMC5685050	['[12]conducted the largest-scale examination of Vitamin D status in thai population and reported a 45.2% prevalence rate of Vitamin D insufficiency, defined as Serum 25(Oh)D level\xa0<\xa030\xa0ng/ml (<75\xa0nmol/l) a 5.7% prevalence rate of Vitamin D deficiency, defined as Serum 25(Oh)D level <20\xa0ng/ml (<50\xa0nmol/l).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('CHEBI_71657', 'versiconol acetate', 165, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 165, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('UBERON_0001977', 'blood serum', 262, 'serum'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 268, '25(OH)D')]
S19-PMC5685050	PMC5685050	10/2014	S19-PMC5685050	['[14]assessed Vitamin D status in healthy thai elderly women and found that two-thirds had Vitamin D insufficiency and one-third had Vitamin D deficiency.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
S22-PMC5685050	PMC5685050	10/2014	S22-PMC5685050	['[15]evaluated Vitamin D status in a younger group of Premenopausal women found the prevalence of Vitamin D insufficiency to be 77.8%, which was as high as the rate found in elderly thai women living in nursing homes.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 53, 'premenopausal'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S24-PMC5685050	PMC5685050	10/2014	S24-PMC5685050	['[16]evaluated Vitamin D status in healthy young thai men and women (age 25–54 years) and found that the prevalence of Vitamin D deficiency was three-fold higher in females than in males (43.1% in females compared to 13.9% in males).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
S32-PMC5685050	PMC5685050	10/2014	S32-PMC5685050	['caption (table-wrap): table\xa01\n\nsummary of Vitamin D status in thai peoplestudychailurkit et\xa0al.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S42-PMC5685050	PMC5685050	10/2014	S42-PMC5685050	['Life style and environmental factors are the major factors that determine Vitamin D status in thai People.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 0, 'Life'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 99, 'people')]
S61-PMC5706533	PMC5706533	11/2017	S61-PMC5706533	['from registry entries of eligible ongoing/planned trials, we extracted information (when available) on geographical location, study status (for example, completed but unpublished, ongoing, not yet started, status unknown), number of participants enrolled, recruitment start date, inclusion and exclusion criteria, details on Vitamin D supplementation dose, frequency and duration, cointerventions, and primary and secondary outcomes that investigators listed in the registry.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 325, 'vitamin D')]
S98-PMC5732505	PMC5732505	12/2017	S98-PMC5732505	['results\nin the study population 97% were Vitamin D sufficient [25(Oh)D\u2009>\u200950\xa0nmol/l] in both mothers and newborns, while optimal Vitamin D status [25(Oh)D above 80\xa0nmol/l] was seen in 52% of the mothers and 45% of the newborns.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 69, 'D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 152, 'D')]
S111-PMC5732505	PMC5732505	12/2017	S111-PMC5732505	['1\n\nmaternal Vitamin D status and Gestational diabetes mellitus.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'gestational')]
S2-PMC5758521	PMC5758521	1/2018	S2-PMC5758521	['in a singleton Birth cohort (n\u2009=\u2009248), Vitamin A and e nutritional status in fetuses/newborns were assessed by Cord Plasma concentrations of Retinol, β-Carotene, Α- and γ-tocopherols.']	N/A	N/A	[('GO_0007567', 'parturition', 15, 'birth'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('UBERON_0002240', 'spinal cord', 111, 'cord'), ('UBERON_0001969', 'blood plasma', 116, 'plasma'), ('CHEBI_26536', 'retinoic acid', 141, 'retinol'), ('CHEBI_23042', 'carotene', 152, 'carotene'), ('CHEBI_16199', 'urea', 162, 'α-')]
S33-PMC5758521	PMC5758521	1/2018	S33-PMC5758521	['for assessing Vitamin A and E nutritional status in fetuses/neonates, Retinol, Β-Carotene, Α-Tocopherol and Γ-Tocopherol in edta cord plasma specimens were measured by high-performance liquid chromatography (hplc)18.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 28, 'E'), ('CHEBI_26536', 'retinoic acid', 70, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 79, 'β-carotene'), ('CHEBI_27725', 'butin', 91, 'α-tocopherol'), ('CHEBI_27725', 'butin', 108, 'γ-tocopherol')]
S89-PMC5812027	PMC5812027	2/2018	S89-PMC5812027	['1\n\nflow chart of the study inclusion\n\ncaption (table-wrap): table 1\n\ncharacteristics of the Pregnant women and their infants at Birthmeansdbirth weight (grams)a3542537.7birth length (cm)a502.3gestational age at Delivery (days)28012.4gestational age t1 (days)7613.8gestational age t3 (days)23412.9maternal s-25Ohd t1 (nmol/l)6424.4maternal s-25Ohd t3 (nmol/l)7534.4n (%)male gender of infanta976 (49.8)small for Gestational age (weight or length)93 (4.5)low Birth weight (<\u20092500\xa0g)58 (2.8)Preterm Delivery (<\u200937\xa0weeks)78 (3.8)spontaneous Preterm Delivery (<\u200937\xa0weeks)55 (2.7)Pregnancy loss97 (4.7)Intrauterine fetal death (≥\u200922\xa0weeks)9 (0.5)\nt1 first trimester, t3 third trimester, 25Ohd 25-Hydroxyvitamin D\nalive Born infants only\n\ncaption (table-wrap): table 2\n\nthe Pregnant women’s Vitamin D status in the first (t1) and third (t3) Trimester of Pregnancy, and their characteristics (mean or percent) grouped by 25Ohd concentration in (t1)t1 25Ohd (nmol/l)<\u20093030–49.950–74.975–99.9≥\u2009100n198291788565125%10.114.840.128.76.4bmi t1 (kg/m2)25.124.924.423.924.4age t1 (years)29.430.931.632.032.4born in sweden (%)14.154.683.387.893.5tobacco use t1 (%)6.84.64.04.61.6nulliparous t1 (%)34.842.042.643.142.7vitamin D supplement use t1 (%)10.628.245.256.662.9university level education (%)32.354.961.367.366.1small for Gestational age (%)5.74.25.34.14.0preterm Delivery (%)4.15.23.83.91.6low Birth weight (%)3.04.53.12.11.6pregnancy loss (%)6.35.64.55.10t3 25Ohd (nmol/l)<\u20093030–49.950–74.975–99.9≥\u2009100n163330473409443%9.018.226.022.524.4small for Gestational age (%)7.55.54.74.62.3preterm Delivery (%)4.31.23.62.21.6low Birth weight (%)4.30.32.71.21.4\nt1 first trimester, t3 third trimester, 25Ohd 25-hydroxyvitamin d\n\nBirth size and Preterm Delivery\nin total, 93 (4.5%) infants were Born sga.']	N/A	N/A	"[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('GO_0002211', 'behavioral defense response to insect', 128, 'birthMeanSDBirth'), ('GO_0007567', 'parturition', 211, 'delivery'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 307, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 341, '25OHD'), ('GO_0007565', 'female pregnancy', 411, 'gestational'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007128', 'meiotic prophase I', 488, 'Preterm'), ('GO_0007567', 'parturition', 496, 'delivery'), ('GO_0007565', 'female pregnancy', 537, 'preterm'), ('GO_0007567', 'parturition', 545, 'delivery'), ('GO_0007565', 'female pregnancy', 574, 'Pregnancy'), ('UBERON_0035108', 'temporalis fascia', 596, 'Intrauterine'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 681, '25OHD'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 687, '25-hydroxyvitamin D'), ('GO_0007567', 'parturition', 713, 'born'), ('GO_0007565', 'female pregnancy', 767, 'pregnant'), ('CHEBI_27300', 'vitamin D', 784, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 834, 'trimester'), ('GO_0007565', 'female pregnancy', 847, 'pregnancy'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 913, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 943, '25OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1208, 'D'), ('GO_0007565', 'female pregnancy', 1311, 'gestational'), ('GO_0007567', 'parturition', 1353, 'delivery'), ('GO_0007567', 'parturition', 1384, 'birth'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 1449, '25OHD'), ('GO_0007565', 'female pregnancy', 1539, 'gestational'), ('GO_0007567', 'parturition', 1581, 'delivery'), ('GO_0007567', 'parturition', 1612, 'birth'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 1684, '25OHD'), ('GO_0007567', 'parturition', 1711, 'Birth'), ('GO_0007565', 'female pregnancy', 1726, 'preterm'), ('GO_0007567', 'parturition', 1734, 'delivery'), ('GO_0007567', 'parturition', 1776, 'born')]"
S99-PMC5812027	PMC5812027	2/2018	S99-PMC5812027	['caption (table-wrap): table 3\n\nassociation between Vitamin D status in Pregnancy with Birth size and Pregnancy loss (adjusted logistic regression analysis)small for Gestational ageapreterm Delivery (<\u200937\xa0weeks)blow Birth weight (<\u20092500\xa0g)cpregnancy lossdorci 95%orci 95%orci 95%orci 95%t1 25Ohde\u2003continuous nmol/l1.0030.99–1.010.9960.99–1.010.9990.99–1.010.989*0.98–1.00\u2003\u2003<\u200930 (ref)1.01.01.01.0\u2003\u200330–49.91.0780.44–2.661.6470.63–4.332.5490.88–7.381.0300.44–2.41\u2003\u200350–74.91.6320.69–3.851.2600.47–3.362.2870.77–6.830.6880.29–1.62\u2003\u200375–99-91.2920.51–3.271.3320.48–3.731.6650.51–5.490.8090.33–1.96\u2003\u2003≥\u20091001.2940.38–4.420.5020.09–2.721.2550.22–7.270.000ft3 25Ohde\u2003\u2003<\u200930 (ref)1.01.01.0\u2003\u200330–49.90.7710.34–1.750.3020.08–1.140.071*0.01–0.63\u2003\u200350–74.90.6230.27–1.450.9330.31–2.790.5840.17–1.98\u2003\u200375–99-90.6570.27–1.610.6140.18–2.140.2370.06–1.01\u2003\u2003≥\u20091000.318*0.11–0.900.4460.11–1.760.215*0.05–0.97δ25ohdg\u2003\u2003large increase (≥\u200930\xa0nmol/l) (ref)1.01.01.0\u2003\u2003small increase (0–30\xa0nmol/l)2.564*1.16–5.672.905*1.01–8.343.1220.97–10.09\u2003\u2003decrease (<\u20090\xa0nmol/l)3.679**1.60–8.442.8940.95–8.854.722*1.37–16.28\nt1 first trimester, t3 third trimester, 25Ohd 25-Hydroxyvitamin D\n* p \u2009<\u20090.05 ** p \u2009<\u20090.01\namodels include 92 (t1) and 80 (t3 and δ25ohd) cases of small for Gestational age\nbmodels include 77 (t1) and 43 (t3 and δ25ohd) cases of Preterm Delivery\ncmodels include 57 (t1) and 31 (t3 and δ25ohd) cases of low Birth weight\ndmodels include 96 cases of Pregnancy loss\neadjusted for education, origin, season of Conception and bmi at t1.']	N/A	N/A	"[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0007567', 'parturition', 86, 'birth'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 189, 'delivery'), ('GO_0007567', 'parturition', 215, 'birth'), ('CHEBI_63058', '(2R,3S)-EHNA', 289, '25OHDe'), ('CHEBI_63058', '(2R,3S)-EHNA', 647, '25OHDe'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 1116, '25OHD'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 1122, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1233, 'gestational'), ('GO_0019230', 'proprioception', 1305, 'preterm delivery'), ('GO_0007567', 'parturition', 1382, 'birth'), ('GO_0007565', 'female pregnancy', 1423, 'pregnancy'), ('GO_0007620', 'copulation', 1481, 'conception')]"
S33-PMC5827025	PMC5827025	2/2018	S33-PMC5827025	['caption (table-wrap): table 1\n\ndemographic characteristics of 3598 mothers.demographic variablesgestational Vitamin D status1p -value2deficiencyinsufficiencysufficiencypregnant women [n (%)]1397 (38.83)1260 (35.02)941 (26.15)maternal age [years, n (%)]\xa0\xa0<25\xa0\xa025–34\xa0\xa0≥35220 (15.75)1131 (80.96)46 (3.29)194 (15.40)1022 (81.11)44 (3.49)147 (15.62)768 (81.61)26 (2.77)0.909maternal bmi [kg/m2, n (%)]\xa0\xa0underweight (<18.5)\xa0\xa0normal weight (18.5–22.9)\xa0\xa0overweight (≥23.0)333 (23.84)925 (66.21)139 (9.95)271 (21.51)859 (68.17)130 (10.32)168 (17.85)649 (68.97)124 (13.18)0.003season of Blood sample [n (%)]\xa0\xa0spring\xa0\xa0summer\xa0\xa0fall\xa0\xa0winter477 (34.14)311 (22.26)279 (19.97)330 (23.62)468 (37.14)271 (21.51)275 (21.83)246 (19.52)371 (39.43)225 (23.91)193 (20.51)152 (16.15)0.001periconceptional Multivitamin use [n (%)]\xa0\xa0no\xa0\xa0less than one month\xa0\xa0more than one month1220 (87.33)97 (6.94)80 (5.73)1033 (81.98)112 (8.89)115 (9.13)743 (78.96)81 (8.61)117 (12.43)<0.001family monthly income (rmb/yuan) [n (%)]\xa0\xa0low (<2000)\xa0\xa0middle (2000–3999)\xa0\xa0high (≥4000)611 (43.74)590 (42.23)196 (14.03)557 (44.21)516 (40.95)187 (14.84)432 (45.91)372 (39.53)137 (14.56)0.746parity [n(%)]\xa0\xa01 >11345 (96.87)60 (3.13)1238 (96.97)51 (3.03)927 (96.58)37 (3.42)0.854gestational week of Blood sample [w, n (%)]\xa0\xa0first-trimester (<13)\xa0\xa0second-trimester (13–27)519 (37.15)878 (62.85)444 (35.24)816 (64.76)337 (35.81)604 (64.19)0.575\n125(Oh)D < 20\u2009ng/ml for deficiency; 20\u2009≤\u200925(Oh)D < 30\u2009ng/ml for insufficiency; 25(Oh)D ≥ 30\u2009ng/ml for sufficiency.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000178', 'blood', 577, 'blood'), ('CHEBI_7025', 'mupirocin', 781, 'multivitamin'), ('UBERON_0000178', 'blood', 1247, 'blood'), ('CHEBI_84177', '14-HPDHE', 1391, '125(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1432, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1470, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1470, '25(OH)D')]
S63-PMC5827025	PMC5827025	2/2018	S63-PMC5827025	['association between Gestational Vitamin D status and the risk of Preterm Delivery\nthe association between Gestational Vitamin D status and the risk of Preterm Delivery was analyzed.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'preterm'), ('GO_0007567', 'parturition', 73, 'delivery'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'preterm'), ('GO_0007567', 'parturition', 159, 'delivery')]
S66-PMC5827025	PMC5827025	2/2018	S66-PMC5827025	['caption (table-wrap): table 4\n\ncrude and adjusted rrs for Preterm Delivery in different groups.parametergestational Vitamin D statussufficiencyinsufficiencydeficiencygestational week (week)39.3\u2009±\u20091.739.0\u2009±\u20091.5**38.6\u2009±\u20092.5**††Preterm Delivery [n (%)]25 (2.66)48 (3.81)115 (8.23)crude rr (95% ci )1.001.45 (0.89, 2.37)3.28 (2.12, 5.11)**adjusted rr (95% ci )11.002.07 (1.16, 3.71)*4.02 (2.33, 6.92)**††early Preterm Delivery [n (%)]29 (0.97)6 (0.49)34 (2.59)crude rr (95% ci )1.000.50 (0.18, 1.42)2.70 (1.29, 5.66)**††adjusted rr (95% ci )11.000.54 (0.19, 1.51)2.97 (1.41, 6.24)**††late Preterm Delivery [n (%)]216 (1.69)42 (3.32)81 (5.64)crude rr (95% ci )1.001.98 (1.11, 3.55)*3.62 (2.10, 6.23)**††adjusted rr (95% ci )11.002.09 (1.17, 3.74)*3.90 (2.26, 6.72)**††\n1adjusted for pre-Pregnancy bmi, maternal age, Periconceptional multivitamin use, and season of sampling.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 58, 'preterm'), ('GO_0007567', 'parturition', 66, 'delivery'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007622', 'rhythmic behavior', 225, 'Preterm delivery'), ('GO_0019230', 'proprioception', 406, 'preterm delivery'), ('GO_0019230', 'proprioception', 585, 'preterm delivery'), ('GO_0007565', 'female pregnancy', 782, 'pregnancy'), ('GO_0007565', 'female pregnancy', 811, 'periconceptional')]
S69-PMC5827025	PMC5827025	2/2018	S69-PMC5827025	['the association between Gestational Vitamin D status and risk of early Preterm Delivery and late Preterm Delivery were then analyzed.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 24, 'gestational'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'preterm'), ('GO_0007567', 'parturition', 79, 'delivery'), ('GO_0007565', 'female pregnancy', 97, 'preterm'), ('GO_0007567', 'parturition', 105, 'delivery')]
S142-PMC5827025	PMC5827025	2/2018	S142-PMC5827025	['Gestational Vitamin D status was divided into three groups according to following criteria: 25(Oh)D <20\u2009ng/ml for vdd, 20\u2009≤\u200925(Oh)D <30\u2009ng/ml for vitamin insufficiency (vdi), and 25(Oh)D ≥30\u2009ng/ml for Vitamin D sufficiency (vds)5,14.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 92, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 95, 'OH ... D'), ('CHEBI_33010', 'chromide(1-)', 126, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 179, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 179, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 185, 'D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
S75-PMC5838372	PMC5838372	3/2018	S75-PMC5838372	['also, we evaluated the infants according to mother’s Vitamin D status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
S14-PMC5941617	PMC5941617	5/2018	S14-PMC5941617	['Vitamin D2And D3Are transported by Vitamin D binding protein to the Liver, where they are 25-hydroxylated by the Vitamin D-25-hydroxylase (Cyp2R1) to produce 25-Hydroxyvitamin D [25(Oh)D], the major circulating Vitamin D Metabolite which is used to evaluate individual Vitamin D status.']	N/A	N/A	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 0, 'Vitamin D2and D3are'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D2and D3are'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002107', 'liver', 68, 'liver'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 139, 'CYP2R1'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 158, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 179, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 221, 'metabolite'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
S83-PMC5952272	PMC5952272	5/2018	S83-PMC5952272	['an unsatisfying status was also observed for Vitamin D whose mean Serum level did not meet the reference value in any of the sub-groups, with more than two-thirds of the women being deficient.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001977', 'blood serum', 66, 'serum')]
S88-PMC5952272	PMC5952272	5/2018	S88-PMC5952272	['status of (a) Vitamin E and (b) Vitamin D in Pregnant women (18-43 years) by Trimester and province assessed through Serum levels.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 45, 'pregnant'), ('GO_0009294', 'DNA mediated transformation', 77, 'trimester'), ('UBERON_0001977', 'blood serum', 117, 'serum')]
S97-PMC5952272	PMC5952272	5/2018	S97-PMC5952272	['status of (a) Vitamin E and (b) Vitamin D in Lactating women (18-48 years) by province assessed through Serum levels.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 45, 'lactating'), ('UBERON_0001977', 'blood serum', 104, 'serum')]
S104-PMC5952272	PMC5952272	5/2018	S104-PMC5952272	['status of (a) Vitamin E and (b) Vitamin D status in children (6-59 months) by sex and province assessed through Plasma levels.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 112, 'plasma')]
S102-PMC5956785	PMC5956785	5/2018	S102-PMC5956785	['2000 51°n [49]jca n \u2009=\u200934 (23f)9.2 (4.6–13.6)estimated from graph\xa045 (14.5–62.5)Vitamin D status was significantly lower in jca patients than age-matched controls before treatment, Steroid-treated children have low Vitamin D. all but three children received Corticosteroids.control group 25(Oh)D estimate 75\xa0nmol/l.florence, italy falcini et al.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('CHEBI_35341', 'steroid', 181, 'Steroid'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 258, 'corticosteroids'), ('CHEBI_71657', 'versiconol acetate', 288, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 288, '25(OH ... D')]
S128-PMC5956785	PMC5956785	5/2018	S128-PMC5956785	['1993 40°n [42]jra n \u2009=\u200927 (23)2.9–1684.9\u2009±\u200911.0no difference in Vitamin D status between active and inactive groups.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
S190-PMC5956785	PMC5956785	5/2018	S190-PMC5956785	['as latitude increases more studies report a difference in Vitamin D status between patients with active versus inactive disease in comparison to lower latitudes as illustrated in fig.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S7-PMC6011374	PMC6011374	6/2018	S7-PMC6011374	['a 53% decreased risk for Gestational diabetes mellitus (gdm) was observed with high (>\u200981\xa0nmol/l) “standardised” Vitamin D status when compared to moderate-high (63–81\xa0nmol/l, arr, 0.47; 95% ci: 0.23, 0.96).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 25, 'gestational'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
S8-PMC6011374	PMC6011374	6/2018	S8-PMC6011374	['marginal sex-specific differences occurred between Vitamin D status and gdm: women carrying a female fetus had a 56% decreased risk for gdm in those with low-moderate levels of standardised Vitamin D (44–63\xa0nmol/l) compared to moderate-high levels (arr: 0.44; 95% ci: 0.20, 0.97), whilst in women carrying a male fetus, a 55% decreased risk of gdm was found with high standardised Vitamin D when compared to moderately-high Vitamin D, but this was not statistically significant (arr: 0.45; 95% ci: 0.15, 1.38).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 424, 'vitamin D')]
S54-PMC6011374	PMC6011374	6/2018	S54-PMC6011374	['potential confounders for Vitamin D status were assessed using linear modelling.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
S78-PMC6011374	PMC6011374	6/2018	S78-PMC6011374	['when women were categorised based on clinical definitions of Vitamin D deficiency and Serum 25(Oh)D between 50 and 75\xa0nmol/l used as the reference, no significant relationship between Vitamin D status and adverse Pregnancy outcome was found (table2).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy')]
S85-PMC6011374	PMC6011374	6/2018	S85-PMC6011374	['similar results were observed when Vitamin D status was based on clinical definitions of deficiency (additional file1: table s1).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
S124-PMC6011374	PMC6011374	6/2018	S124-PMC6011374	['adjusted relative risks (arr) of Pregnancy complications from any complication, preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaeous preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status and stratified by fetal sex.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('GO_0007565', 'female pregnancy', 99, 'gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007567', 'parturition', 186, 'birth'), ('GO_0007565', 'female pregnancy', 213, 'gestational'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
S204-PMC6056931	PMC6056931	7/2018	S204-PMC6056931	['the iron status indices, ferritin and Transferrin receptor, as well as the Vitamin A status indicator Retinol binding protein will be determined using the q-plex™ Human Micronutrient array (7-plex, quansys bioscience, logan, ut, usa) [69].']	N/A	N/A	[('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 38, 'transferrin'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 102, 'retinol'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'Human'), ('CHEBI_6956', 'Mitragynine', 169, 'Micronutrient')]
S16-PMC6011374	PMC6011374	6/2018	S16-PMC6011374	['Vitamin D status is determined by measuring circulating Serum levels of 25-Hydroxy Vitamin D2\u2009+\u20093(25(Oh)D).']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 72, '25-hydroxy'), ('CHEBI_28934', 'vitamin D2', 83, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 83, 'vitamin D2'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
